Opening requested calculation...
Please wait, this takes like 47 seconds. Thank you for your patience! :)
☠
0 humans have been terminated by curable diseases since this page started loading
Intermediation cost of governance in the United States: $4.9 trillion (95% CI: $3.62 trillion-$6.5 trillion) per year. People employed to execute functions that are algorithmic in nature: millions. Time since the technology to replace them became available: 17 years. Number of agencies replaced: zero. This is a technical specification for the obvious.
Introduction
A citizen who wants cancer research funded must persuade a representative, who must negotiate with other representatives, who must instruct an agency head, who must direct a bureaucracy, who must process applications, who must distribute funds. Six intermediaries between “I want this” and “this happens.” Each layer extracts value (salaries, overhead, compliance costs) and introduces preference distortion (lobbying, logrolling, regulatory capture). The aggregate cost of this intermediation in the United States alone is $4.9 trillion (95% CI: $3.62 trillion-$6.5 trillion) per year157, or 17% (95% CI: 12.6%-22.6%) of GDP.
Most of what these intermediaries do is mechanical. Tax calculation, benefit distribution, budget allocation, auditing, census enumeration: these are algorithms being executed by humans. Humans are slower, more expensive, and more susceptible to capture than actual algorithms. They also require lunch breaks, health insurance, and the occasional bribery budget.
This paper describes a protocol that replaces specific mechanical agency functions with deterministic code while preserving democratic control over what those functions do. Citizens still decide how resources are allocated, through pairwise preference aggregation (Wishocracy158). The protocol executes their decisions without extracting value at each administrative layer.
We do not propose replacing government. We propose replacing the intermediaries between citizens and governance outcomes. Democracy is a decision-making system, not an employment program. The functions that require human judgment (enforcement, diplomacy, adjudication) remain human. The functions that are algorithmic in nature become actual algorithms. This is the same category of innovation as the dishwasher. The dishwasher replaced dishwashing, not cooking. Nobody argued that dishes required human judgment. Nobody wrote an op-ed titled “In Defense of Dirty Dishes.” The objections to algorithmic governance are identical to the objections people would have raised about dishwashers if dishwashers also eliminated the jobs of people who write regulations about dishwashing.
System Architecture
The protocol has five parts:
Transparent ledger. Every government transaction recorded on a shared, publicly auditable ledger. Private settlements record only the minimal fields needed for tax collection and macro measurement, with identities and item-level details proved privately. Eliminates ex-post auditing (GAO) and opacity-dependent corruption.
Preference aggregation (Wishocracy). Verified citizens in the relevant jurisdiction express resource allocation preferences through ~20 pairwise comparisons. The RAPPA algorithm158 produces budget weights via eigenvector decomposition and, when legal change is required, direct rule mandates. Eliminates congressional appropriations, OMB, and much committee bargaining.
Evidence engine (Optimocracy). Cross-jurisdictional causal inference160 compares policy outcomes across thousands of jurisdictions and identifies which policies actually make people richer and less dead (median income, healthy life years). Eliminates the CBO’s scoring function.
Identity layer. Continuous, sybil-resistant citizen verification. Every verified citizen receives equal allocation weight and equal UBI distribution. Eliminates the decennial census and means-testing bureaucracy.
Automated monetary policy. Fixed algorithmic rule targeting 0% change in a rule-bound purchasing-power basket. A final-consumption settlement tax funds the budget, a separate stabilization component is burned or parked in reserve as needed, and new money creation equals productivity growth. The productivity dividend is distributed equally via UBI. Eliminates the Federal Reserve’s discretionary monetary policy.
These five primitives are interdependent. An engineer would call this a system. Your species calls it five separate agencies with five separate budgets, five separate directors, and five separate lobbying targets. The ledger enables accountability without auditors. Wishocracy enables allocation without appropriators. The evidence engine enables informed preferences without policy analysts. Identity enables distribution without means-testing. Monetary policy enables stable prices without central bankers. Remove any primitive and the system degrades.
Monetary Policy and Revenue
The Problem
The full case against discretionary monetary policy fills its own chapter. The short version: twelve unelected people sit around a table and decide how much your money is worth. The dollar has lost 96% of its purchasing power since they started. New money enters the economy at the top (banks, government contractors) and reaches citizens last, after each intermediary has captured value. This is the Cantillon effect. It is not a bug. It is the system. The mechanism has funded unpopular wars that killed 310 million people without requiring democratic consent for any of them. The technology to replace the table has existed since 2009. Your species is using it to trade pictures of monkeys.
The FairTax, Implemented Algorithmically
The tax and monetary architecture is not novel. It is the FairTax (a consumption tax replacing all income taxes, with a universal prebate) implemented at the protocol level with three modifications: (1) collection happens automatically at settlement, (2) the displayed rate is set by an algorithm instead of Congress, and (3) the prebate is a daily UBI deposit instead of a monthly check.
The system has two moving parts:
The settlement tax replaces all income, payroll, capital gains, corporate, and estate taxes with a single flat percentage collected automatically at final-consumption settlement. Consumer purchases are taxed. Transfers between registered business accounts, capital formation, and pure balance-sheet reallocations are zero-rated automatically by wallet type, so the tax does not pyramid through supply chains. No filing. No deductions. No code. No IRS. The consumer sees one number at checkout.
Behind that one visible rate are two destinations. The fiscal component funds the government’s wishocratically-determined budget. The stabilization component does not fund spending; when activated, it is burned or parked in a non-spendable reserve until the purchasing-power basket returns to target. This is the minimum machinery required to avoid a conceptual error: the same tax dollar cannot both finance expenditure and disappear from circulation.
Once every citizen and business can hold verified settlement wallets directly on the protocol, banks cease to be necessary as deposit warehouses, payment rail operators, and first receivers of new money. What survives is lending. Underwriting default risk, duration risk, and project selection remain real work. Mortgages, business loans, and venture finance still exist, but they are funded by competitive credit pools layered on top of the protocol rather than by institutions that also control custody and payments.
The UBI deposit replaces means-tested cash welfare with a daily payment to every verified citizen. UBI has three funding streams, each from a different source:
- Structural dividend: all fiscal cash the protocol directly captures or consolidates by default: eliminated agency operating costs, reclaimed direct spending waste, recovered tax gap, and the transfer-like portion of the welfare state rewritten from category-specific entitlements into equal cash. In long-run steady state, retirement cash support can be folded into the same base as legacy promises roll off. What remains outside the universal cash stream is not an open-ended sympathy bureaucracy but a narrow catastrophic frontier (the short list of disasters too expensive for any one person to handle alone): pooled catastrophic risk, child-linked funding, and incapacity management for citizens who literally cannot manage cash on their own behalf.
- Productivity dividend (this section): new currency minted by the algorithm to prevent deflation as the economy grows. This is the Cantillon pipeline, redirected from banks to citizens.
- Democratic supplement: whatever additional share of the ordinary discretionary budget citizens explicitly choose to direct to cash transfers versus other public goods.
The citizen sees one deposit, but the sources are distinct: captured fiscal cash, monetary issuance, and democratic choice.
These are the monetary control levers:
- Prices rising (inflation): The algorithm increases the stabilization component of the settlement tax. Those receipts are not spent back into the economy. They are retired or sequestered until the price basket returns to target. The fiscal component changes only as needed to fund the budget.
- Prices falling (deflation from productivity growth): The algorithm reduces the stabilization component toward zero. If prices continue falling because output is growing faster than money velocity, the algorithm mints new currency and distributes it via the productivity dividend. This is new money representing real economic growth, entering at the bottom instead of the top.
The combination of a fiscal rate, a temporary sterilization rate, and a productivity dividend maintains stable purchasing power without human discretion.
Why 0% and not deflation. A growing economy with a fixed money supply produces natural deflation: more goods, same money, falling prices. The central-banks chapter documents that the longest sustained deflation in American history (1870-1896) coincided with explosive economic growth. Natural deflation works. But the protocol targets 0% inflation instead, for three reasons:
- Adoption. “$200 per month in your account” is a campaign slogan. “Prices fell 1.8% and your purchasing power increased by an equivalent amount” is a lecture. The protocol needs adoption. Adoption requires a benefit people can feel. Cash is felt. Deflation is not.
- Debt neutrality. Deflation makes existing debts more expensive in real terms. Every mortgage, student loan, and business loan costs more when prices fall. The 0% target is neutral: it neither inflates away debts (theft from savers) nor deflates them larger (punishment for borrowers).
- The real complaint is distribution, not deflation. The central-banks chapter argues against the Federal Reserve. The core objection is not “deflation should be allowed.” It is “new money should not go to banks first.” The protocol fixes the distribution. New money is still created (to prevent deflation), but it enters at the bottom (UBI to every citizen) instead of the top (Cantillon pipeline to banks). The same productivity gains reach the same citizens. The check just arrives as cash instead of as imperceptibly cheaper groceries.
This is a pragmatic choice, not a theoretical one. An economically purer design would allow natural deflation and skip the monetary UBI entirely. The structural dividend would still exist. But the productivity dividend distributed as cash is the single most powerful adoption incentive the protocol has. Theoretical purity that never gets adopted helps nobody.
Where the Inflation Money Goes
Under the current system, the Federal Reserve creates new money and routes it through banks. The banks lend it, spend it, or invest it before prices adjust. By the time rising prices reach your grocery store, the purchasing power has already been captured by whoever touched the new money first. This is not a side effect. It is the product. The Fed expanded its balance sheet by roughly $4.8 trillion in 2020-2022 alone. The top 1% gained approximately $4 trillion in net worth over the same period. This is considered a coincidence by people who benefit from it being considered a coincidence. The mechanism is the Cantillon effect described in the central-banks chapter, and it has been operating for over a century.
Under the protocol, when new money must be created to keep the basket stable as output grows, it is created at the bottom and distributed equally. The productivity dividend goes directly to every verified citizen in the jurisdiction as UBI. The monetary function is the same. The first receiver changes.
This is not a new discretionary privilege layered on top of the old system. It is the monetary function the Federal Reserve already performs, reassigned from banks to citizens. The claim is not that every future issuance episode will match some past Fed episode dollar-for-dollar. The claim is that whenever money creation occurs, the Cantillon advantage disappears.
Why Not CPI
The algorithm targets 0% change in a purchasing-power basket. The measurement matters. If the price index is wrong, the algorithm stabilizes the wrong thing.
The Consumer Price Index (CPI), compiled by the Bureau of Labor Statistics, has well-documented biases that systematically understate inflation:
- Substitution bias. When steak gets expensive, the BLS assumes you switch to chicken. “Inflation” stays low because the basket changed, not because prices did. You ate worse. The index says you are fine.
- Hedonic adjustment. Your laptop costs the same as last year but has a faster processor. The BLS counts this as a price decrease. You paid the same amount. The index says you paid less.
- Owner’s equivalent rent. Instead of measuring what housing actually costs, the BLS asks homeowners what they think their house would rent for. Housing prices doubled in many markets between 2020 and 2024. CPI barely noticed.
- Geometric weighting. A technical adjustment that systematically lowers the measured rate by assuming you keep switching to whatever is cheapest. This is a math trick that makes inflation smaller on paper.
The institution compiling CPI is the same government that benefits from reported inflation being low (lower Social Security COLA adjustments, lower inflation-indexed bond payouts, lower TIPS returns). No sane audit process lets the defendant grade their own exam.
The protocol uses a different metric: a rule-bound purchasing-power basket derived from actual settlement data on the ledger. The algorithm does not rely on surveys or hedonic imputations. It observes actual cleared prices. For private transactions, the ledger exposes only the fields needed for macro measurement and tax collection: amount, standardized category, jurisdiction, and time bucket. Identities, counterparties, and item-level receipts remain private and are validated with zero-knowledge proofs. There is no owner’s-equivalent-rent fiction because the system uses actual rents and observed housing transaction data.
The price index is anchored to essential goods: energy, food, housing, healthcare, and a precious metals component (gold and silver) that provides a manipulation-resistant floor. Basket weights are derived from observed spending patterns, locked for a governance interval, and updated only on a public schedule rather than continuously chasing substitution patterns. The entire calculation is public and auditable on the ledger. Anyone can verify it. Nobody can adjust it.
Why No Gold Standard
The central-banks chapter demonstrates that gold-anchored systems produced broad-based prosperity (Bretton Woods, the classical gold standard) while fiat systems produced wage stagnation and wealth concentration. A reasonable person might conclude: go back to gold.
The protocol achieves the gold standard’s benefit (constraining money creation) through a different mechanism. Gold constrained money creation by requiring a physical reserve. The algorithm constrains money creation by targeting a purchasing power index. Both prevent politicians from printing money for wars or bailouts. The algorithm has three advantages over gold:
- It can accommodate growth. Under a gold standard, a growing economy produces deflation (more goods, same gold supply), which passively rewards existing holders. The algorithm creates exactly enough new currency to keep prices stable, distributing the growth dividend to citizens instead of to vaults.
- It cannot be suspended. Every gold standard in history was abandoned when a government needed to fund a war. The algorithm runs on a distributed ledger that no single government controls. Suspending it requires a majority of nodes, not a Sunday evening press conference.
- It is auditable in real time. The total money supply, public spending flows, and the macro fields used by the monetary rule are visible on the ledger. Gold reserves required trusting that the metal was actually in the vault. (It frequently was not. See: Nixon, 1971.)
The “backing” is not a metal. It is a guarantee: this currency will buy the same basket of goods tomorrow as it does today. That is a stronger guarantee than “this currency can be exchanged for a specific weight of a metal whose own value fluctuates based on jewelry demand and mining output.”
What This Replaces
| Federal Reserve (12 FOMC members, ~24,000 staff, ~$6.8B/year) |
Deterministic algorithm |
0% inflation target; cannot be lobbied |
| 2% annual inflation (96% cumulative loss since 1913) |
0% target |
Stable purchasing power |
| Cantillon effect (proximity to printer = wealth) |
Equal-entry money creation |
New money enters at the bottom |
| Commercial banks as money utilities |
Protocol wallets + competitive credit funds |
Custody and settlement become protocol functions; lending remains a risk-priced service |
| Income/payroll/capital gains taxes + IRS |
Algorithmic final-consumption settlement tax |
Collected automatically at settlement |
| Congressional tax rate debates |
Automated fiscal + stabilization adjustment |
Budget funding separated from monetary control |
The Tax System It Replaces
The previous section describes the protocol’s final-consumption settlement tax. This section describes what it replaces, and why the replacement is overdue.
In 1913, the federal income tax fit in 27 pages. Today, the federal tax system (the Internal Revenue Code plus Treasury regulations, rulings, and case law) fills approximately 74,000 pages of the CCH Standard Federal Tax Reporter. Each page beyond the original 27 represents a successful lobbying effort: an exemption, a deduction, a credit purchased by an industry that benefits from it. The tax code is not a revenue collection mechanism. It is a geological record of every deal ever struck between a legislator and a donor, compressed into sedimentary layers of subsection and cross-reference.
Americans spend 6.1 billion hours per year on tax compliance. To put that in a unit humans can feel: the Apollo program employed 400,000 people at its peak. Americans dedicate the equivalent labor of 15 Apollo-scale workforces every year to tax paperwork. You could staff fifteen moon landings annually with the human effort currently dedicated to interpreting a document whose primary function is to be uninterpretable.
The IRS employs over 100,000 people (up from ~79,000 in 2021). The agency’s own operating budget is about $14 billion, while the tax system built around it imposes $546 billion (95% CI: $450 billion-$650 billion) per year137 in direct compliance burden on the rest of society. Regulatory compliance adds another $580 billion (95% CI: $290 billion-$1 trillion) per year53.
The compliance industry (tax preparers, accountants, software companies) has a structural interest in complexity. Intuit, the maker of TurboTax, has spent millions lobbying against IRS proposals to offer free, pre-filled tax returns. The IRS could pre-fill most returns using data it already has (employers report wages; banks report interest; brokerages report gains). It does not, partly because the compliance industry lobbies against it. You are paying to solve a problem that the people you are paying have a financial interest in not solving. There is a word for this. The word is “protection racket.” Your species uses the same word. You just don’t apply it when the racketeer files a 10-K.
What This Replaces
| IRS (~100,000 employees) |
Protocol-level function |
$546 billion (95% CI: $450 billion-$650 billion)/year direct |
| 74,000-page tax code |
One rate, applied uniformly |
6.1B hours/year compliance eliminated |
| Tax compliance industry |
Ceases to exist |
$200B+/year in private compliance costs |
| Tax evasion (~$600B/year net gap) |
Low-rate settlement tax + UBI conditional on on-ledger identity |
~$500B+/year recovered |
The 27-page tax code of 1913 could have been a function. The 74,000-page version is a jobs program for people who interpret the function. The 74,000 intervening pages are the longest suicide note a tax system ever wrote. The protocol returns to the function.
Allocation
The Problem
The United States federal budget is approximately $6.8 trillion, allocated by 535 members of Congress through committee negotiations, floor votes, conference reports, and approximately $4.4 billion (95% CI: $3.74 billion-$5.06 billion) per year in lobbying. The CBO (275 analysts) scores proposed legislation over weeks or months. The OMB (~530 staff, $143M/year) prepares the President’s budget request. By the time the budget is enacted (if it is enacted; your government has shut down over 20 times since 1976 because 535 people could not agree on how to spend money), the document reflects donor preferences filtered through electoral incentives filtered through committee seniority filtered through floor amendments filtered through conference negotiations. At no point in this process does any citizen directly express a preference about how their money is spent.
You pick one human to represent your preferences on thousands of issues. This is like choosing a chef who will eat for you for four years. You wanted the salad. He ordered the war. You can pick a different chef in November, but only from a menu of two, and both chefs are being paid by the steak lobby.
Representatives are elected on bundled platforms (immigration + healthcare + defense + education), making issue-level preference expression impossible. A voter who wants more cancer research and less military spending cannot express this. They get a package deal, designed by consultants, funded by donors, and tested on focus groups. The package is designed to win elections, not to represent you. Resource allocation reflects the preferences of the people who funded the campaign, not the people who voted in it. This is the principal-agent problem operating at the scale of a $6.8 trillion budget, with a $4.4 billion (95% CI: $3.74 billion-$5.06 billion)/year lobbying industry whispering in the agent’s ear158.
The Protocol
Wishocratic preference aggregation replaces the appropriations process and, when needed, the committee bottleneck in rulemaking.
Each verified citizen in the relevant jurisdiction performs ~20 pairwise comparisons: “Would you prefer $100 toward medical research or $100 toward military spending?” The slider allows continuous allocation (85/15, 60/40), not binary choice. The RAPPA algorithm aggregates preferences into budget weights using eigenvector decomposition, the same mathematics that powers Google’s PageRank.
The Optimocracy evidence engine160 informs these comparisons. Before allocating, citizens see what actually works: “Investing $1 in cancer research produces $X in economic value over 10 years.” Preferences expressed with access to evidence differ systematically from preferences expressed without it. That is the point.
Budget weights update continuously. There is no annual budget cycle, no continuing resolution, no government shutdown. The algorithm does not need to agree with itself. It just does the math.
Some problems are budgetary and some are legal. If the question is how much to spend, Wishocracy allocates the money. If the question is whether a tariff, subsidy, or zoning restriction should exist, the same evidence interface presents a direct citizen rule vote instead of routing the decision through committees and donors.
What This Replaces
| Congressional appropriations (535 members) |
Verified citizens in the relevant jurisdiction, direct allocation |
RAPPA eigenvector |
| OMB (~530 staff, $143M/year) |
Wishocratic budget weights |
Automated |
| CBO (275 analysts, months per score) |
Optimocracy engine |
Real-time empirical scoring |
| Grant committees |
Wishocratic allocation weighted by DALYs |
Disease burden determines funding |
| Lobbying industry ($4.4 billion (95% CI: $3.74 billion-$5.06 billion)/year) |
No intermediary to lobby |
Function ceases to exist |
Your government has shut down 20+ times because humans could not agree on a spreadsheet. The algorithm does not shut down. It has no opinion about the spreadsheet. It just fills it in.
Distribution
The Problem
The United States spends over $1.1 trillion per year on means-tested welfare programs across 89 federal programs. Of that, roughly $100 billion goes to administration: determining who qualifies, processing applications, verifying eligibility, preventing fraud. The defining feature of this system is not the benefits. It is the gate. The United States has built a system whose primary purpose is to determine whether you deserve help, and whose primary effect is to ensure you don’t get it in time.
The administrative cost per dollar distributed varies by program, but the pattern is consistent: a significant fraction of every welfare dollar goes not to the poor person but to the bureaucracy deciding whether they are poor enough. SNAP (food stamps) spends roughly 6-7% on administration. Medicaid spends approximately 5%. Housing assistance programs spend roughly 8% on administrative fees. These percentages sound small until you multiply them by hundreds of billions. The United States employs hundreds of thousands of people whose primary function is gatekeeping access to funds that, in many cases, cost less than the gate.
The cruelty is structural. The people who need help most (the disabled, the elderly, non-English speakers, the severely ill) are the least capable of navigating application processes. The system selects for form-filling ability, not need. A healthy 30-year-old with internet access can complete a SNAP application in an afternoon. A disabled 70-year-old who needs the benefits more urgently may not complete it at all. Social Security disability claims take an average of 7-8 months for initial determination (230 days in FY2024, up 81% from 121 days in 2019). Appeals take years. People die waiting. The system designed to prevent their suffering becomes, through administrative delay, the mechanism of their suffering.
The gate costs more than what is behind it. Removing the gate is not a radical policy innovation. It is arithmetic.
The Protocol
Universal Basic Income, deposited daily to every verified citizen via smart contract.
The UBI has three funding layers. The structural dividend is the fiscal cash the protocol directly captures or consolidates by default: eliminated agency operating costs, reclaimed direct spending waste, recovered tax gap, and the transfer-like portion of the welfare state rewritten from category-specific entitlements into equal cash. In long-run steady state, retirement cash support can be folded into the same base as legacy promises roll off. What remains outside the universal cash stream is not an open-ended sympathy bureaucracy but a narrow catastrophic frontier: pooled catastrophic risk, child-linked funding, and incapacity management for citizens who literally cannot manage cash on their own behalf. The productivity dividend is the monetary distribution described above. The democratic supplement is whatever additional share of the ordinary discretionary budget citizens allocate to direct cash transfers through wishocratic preference. This section is about the distribution mechanism: one account, one formula, one daily deposit.
No application. No eligibility determination. No means test. No caseworker. No waiting period. The ledger verifies citizenship (identity layer), calculates the per-citizen amount (total UBI pool / citizen count), and distributes. Every day. To everyone.
Maximum workable UBI does not mean pretending one flat check can replace civilization. It means cashing out everything that is fundamentally a transfer and making the residual exception layer brutally rule-bound. Catastrophic health risk remains pooled through a protocol-defined catastrophic insurance layer rather than a caseworker gate or a blank-check entitlement. Child education remains a per-child voucher or credit rather than adult cash. Everything else that is basically a transfer becomes cash. This should take about a week to figure out. It has taken your species 89 federal programs.
The federal layer should therefore do only four things in distribution: guarantee the universal cash floor, guarantee catastrophic portability, finance child-linked base funding, and move money. States and localities should handle most service delivery: schools, land use, provider markets, supplementary services, and local top-ups. Incapacity cases are handled through explicit representative-payee or guardianship rules, not by recreating a giant means-tested bureaucracy. That is the maximum-cash design that still respects risk pooling, children, and federalism.
The Objective Function
If this system is serious, it should be designed for how people actually behave, not how you wish they would. The terminal objective is the same one used in Optimocracy: maximize real after-tax median income and median healthy life years. Those are the scoreboard metrics. Everything else here is mechanism design in service of those two numbers.
At the protocol-design level, the target can be written as:
\[
\max_R \left[\Delta \widetilde{Y}^{after-tax}_{median}(R) + \theta \, \Delta \widetilde{HLY}_{median}(R)\right] - \lambda A(R)
\]
where (^{after-tax}{median}) is real after-tax median income, ({median}) is median healthy life years, and (A(R)) is the arbitrage value the rule set itself creates for gaming, lobbying, overbilling, denial, or misreporting. Median rather than average is the point: the protocol is trying to make the person in the middle richer and less dead, not make national aggregates prettier while rents concentrate at the top.
In practice, that means maximizing what citizens actually get, given two constraints: money is finite, and people will game whatever you build:
\[
\max_R \sum_i \mathbb{E}\left[u(c_i) + \alpha h_i + \beta s_i - \delta d_i\right] - \lambda A(R)
\]
where (c_i) is disposable consumption, (h_i) is health and human-capital outcome, (s_i) is insurance against ruin, (d_i) is delay and compliance burden, and (A(R)) is the same arbitrage term above. In plain English: maximize median after-tax income and median healthy life years by increasing cash, reducing ruin risk, and minimizing the profit available from manipulating the system.
- Citizens maximize consumption, security, and autonomy. Therefore ordinary redistribution should arrive as unconditional cash. People spend their own money with better local information than a bureaucracy ever has.
- Patients respond to marginal price on routine care but cannot rationally self-insure million-dollar tail risk. Therefore routine care should run through a personal health wallet with rollover, while catastrophe should be pooled.
- Providers maximize reimbursement, not abstract national welfare. Therefore catastrophic coverage should pay published reference or bundled prices, not whatever invoice a hospital emits.
- Insurers and third-party administrators maximize spread by selecting risks, narrowing networks, and denying claims. Therefore they may administer claims or offer supplemental coverage, but they should not control core eligibility, underwriting, or the catastrophic frontier.
- Politicians maximize reelection, donations, and patronage. Therefore recaptured cash should sweep automatically into the structural dividend instead of waiting for annual appropriation horse-trading.
- Bureaucracies maximize budget, headcount, and discretionary turf. Therefore formulas should replace eligibility judgment wherever objective data exist.
- States and localities maximize local voter satisfaction and tax-base protection. Therefore they should control delivery and top-ups, while the federal layer finances a portable floor so jurisdictions cannot dump expensive residents.
Once the utility functions are stated honestly, the design rules become obvious. Give decision rights to the actor with the best local information only when that actor also bears the marginal cost. Citizens decide ordinary consumption from cash. Patients decide routine care from rolling health balances. Providers do not decide the public price of catastrophe. Insurers do not decide who is insurable. Politicians do not get to convert the dividend back into patronage. The point of the protocol is not to assume virtue. It is to leave every actor with less profitable ways to cheat.
The exception rule is ex-ante insurance, not ex-post rescue theater. A category belongs in the public catastrophic layer only if citizens, before knowing who will get sick, would rationally choose to pool that risk rather than take the same dollars as equal cash. In practice, that means five constraints:
- Catastrophic: the loss is too large for ordinary households to self-insure.
- Objective: the trigger is hard to fake.
- Low-frequency / high-severity: this is insurance, not routine spending.
- Reference-priced: the system pays a published schedule, not any number a provider writes down.
- Frontier-tested: the expected welfare gain beats the next-best use of the same dollars, which in this design is usually equal UBI.
One practical implementation is to publish a constitutional catastrophic budget, pay only reference prices, and require every covered intervention to clear a maximum cost-effectiveness threshold benchmarked to $100,000 per QALY unless citizens explicitly vote to fund a different threshold. The public question is therefore never “is this person suffering?” Suffering is everywhere. The question is “does this class of risk beat cash at the margin?” If a proposed intervention fails the catastrophic frontier, public reimbursement is zero. A one-patient trillion-dollar rescue does not become socially optimal just because it is heartbreaking.
Patient cost-sharing should follow the same logic. The place for skin in the game is routine spending, not catastrophe. Preventive care should be zero-price. Ordinary, non-catastrophic care can be paid first from a small personal health wallet funded by an automatic carve-out from UBI or by explicit state/local top-ups. Unused balances roll forward, so economizing benefits the patient directly instead of vanishing into an insurer’s margin. Once a covered episode crosses the catastrophic threshold, the protocol insurance layer pays the reference price and patient cost-sharing falls to zero or a token amount. If a patient chooses a provider charging above the published reference price, the patient pays the difference from ordinary cash.
This matters because most healthcare gaming is provider-side, not patient-side. Upcoding (billing for a disease you don’t have), unbundling (splitting one procedure into five invoices), fake complexity (making simple things look difficult so they cost more), network games (shuffling patients between networks to avoid caps), and price opacity (hiding prices so you can’t shop) are not fixed by scaring patients away from the emergency room. The anti-abuse stack should therefore be reference pricing, bundled payments, transparent outcomes, and anomaly detection first, with modest routine cost-sharing only as a secondary discipline mechanism.
What This Replaces
| SSA (benefit calculation + distribution) |
Single smart contract function |
distribute(total / citizenCount) |
| Cash welfare (SNAP, TANF, SSI) |
Universal cash deposit |
No eligibility bureaucracy |
| Medicaid eligibility determination |
Protocol catastrophic insurance layer + personal health wallet |
Identity verifies citizenship; catastrophic frontier governs pooled coverage |
| K-12 funding bureaucracy |
Per-child education voucher or credit with local top-ups |
Money follows the child; states/localities handle delivery |
| Poverty determination bureaucracy |
Eliminated |
The protocol does not determine desert; it distributes |
| Caseworker-based exception pleading |
Published catastrophic frontier + representative-payee rules |
The protocol does not fund sympathy contests |
The system currently spends more deciding who deserves help than it would cost to help everyone. The protocol helps everyone. The savings come from firing the decision.
Accountability
The Problem
The Government Accountability Office employs approximately 3,600 staff, spends $812 million per year, and produces reports that arrive months or years after the spending they examine. This is because government financial systems are opaque by design. Tracking money through agencies, contractors, and subcontractors requires human investigators who request documents, interview officials, and reconstruct transaction histories from filing cabinets and incompatible databases.
The results are instructive. The Department of Defense has failed its financial audit every single year since audits became mandatory in 2018. Seven consecutive failures through FY2024. The Pentagon cannot account for where trillions of dollars went. The consequence of seven consecutive audit failures: nothing. No budget cut. No personnel change. No criminal investigation. The GAO identified the problem. Congress received the report. The report went into a filing cabinet. The filing cabinet went into a building. The building is still there. So is the problem.
The Freedom of Information Act is the mechanism by which citizens can see how their money is spent. The average FOIA response time is measured in months; complex requests take years. Some agencies have backlogs exceeding 10,000 requests. The system designed to provide transparency has a waiting list. The concept of a “transparency waiting list” is remarkable. It is like a “visibility queue” at a window factory. The window exists. You are not allowed to look through it yet. Please take a number.
The Protocol
When every government transaction is on a public ledger, auditing is not a function. It is a property.
Every unit spent by any governance function is visible to every citizen in real time. There is no document to request. There is no official to interview. The ledger is the audit. Anyone can verify any public expenditure, trace any allocation from wishocratic preference to final disbursement, and confirm that the protocol executed as specified.
What This Replaces
| GAO (~3,600 staff, $812M/year) |
Transparent ledger |
$812M/year + audit lag eliminated |
| Inspector General offices (per-agency watchdogs) |
Redundant; the watched activity is public |
Hundreds of millions/year |
| FOIA requests (months-to-years response time) |
Unnecessary; spending is public by default |
Administrative cost + democratic delay eliminated |
The Pentagon has failed its audit seven years running. A public ledger cannot fail an audit. It is the audit. The distinction is architectural, not aspirational.
Political Incentives
The Problem
Politicians are funded by donors whose interests diverge from citizens’. This is not a theory. It is a business model with documented returns.
$181 billion (95% CI: $150 billion-$220 billion) per year53 in corporate welfare is the direct return on $4.4 billion (95% CI: $3.74 billion-$5.06 billion) per year in lobbying investment. Studies of specific lobbying campaigns have found returns exceeding 22,000%: the American Jobs Creation Act of 2004 provided $62.5 billion in tax breaks to 93 corporations that spent $282.7 million lobbying for it, a return of $220 for every $1 spent. What donors want, they get. What citizens want, they don’t53.
The revolving door completes the circuit. Roughly half of departing members of Congress become lobbyists, monetizing the relationships and access they accumulated in office. The career path is: get elected, learn who controls the money, leave office, sell that knowledge to the people who control the money. The regulator becomes the regulated’s employee. This is not corruption in the legal sense. It is the system working as designed, which is worse, because corruption can be prosecuted and systems cannot.
The Protocol
The Citizen Alignment Score158 measures how closely each politician’s voting record aligns with their constituents’ wishocratic preferences. Campaign funding flows proportionally to alignment: politicians who represent what citizens want receive more electoral resources than politicians who represent what donors want.
The Incentive Alignment Bonds161 fund this mechanism. Bond investors earn returns proportional to treaty expansion and health outcomes; a portion of those returns flows to political incentives that reward alignment.
What This Replaces
| FEC (regulator of donor-driven system) |
Nothing to regulate when there’s nobody to bribe |
Structural elimination |
| Campaign finance ($15.9B in 2024 federal elections) |
Alignment-proportional funding |
Citizens fund representation, not donors |
| Lobbying industry ($4.4 billion (95% CI: $3.74 billion-$5.06 billion)/year) |
No intermediary to lobby |
Function ceases to exist |
The lobbying industry’s return on investment is extraordinary because the intermediary it purchases is cheap. Remove the intermediary and the investment has no target. You cannot bribe an algorithm. You can try, but the algorithm does not have a post-office career to protect.
Identity and Census
The Problem
The United States Census Bureau spent $14.2 billion on the 2020 census. It counted everyone once. The count took months to process. By publication, it was already out of date. The next count is in 2030.
Every American carries a GPS-enabled device that reports its location continuously to at least three private corporations. Your phone company knows where you are right now. Your search engine knows where you were yesterday. Your social media platform can estimate where you will be tomorrow. The government, which ostensibly needs to know where people are, spends $14.2 billion to find out approximately the same information, once per decade, less accurately, and several months late. In a rational civilization, this would be performance art. On Earth, it is the Census Bureau.
The Protocol
Continuous, sybil-resistant citizen verification through the identity layer. Every verified citizen has exactly one identity on the ledger within the jurisdiction in which they vote and receive distributions. The total count is a view function that returns in milliseconds, updated in real time.
The same identity layer prevents double-counting (census), double-spending (monetary system), and double-voting (wishocratic allocation). One primitive serves three functions.
What This Replaces
| Census Bureau ($14.2B per decade) |
Continuous real-time count |
~$1.4B/year amortized |
| Voter registration (separate bureaucracy) |
Merged into identity layer |
Administrative cost eliminated |
| Benefits eligibility verification (per-program) |
Unified in identity layer |
Redundant systems eliminated |
Where the Money Goes
A reasonable person might ask: if the protocol saves trillions, where is that money currently going? The answer requires distinguishing several categories of loss, because they are different in kind and the savings work differently for each.
Agency Operating Overhead
This is the direct public cost of running intermediary agencies. It is real, it is recoverable, and it is smaller than the value currently diverted by captured policy:
| Federal Reserve |
~$6.8B operational |
Deterministic monetary algorithm |
| IRS (agency operations) |
~$14B |
Protocol-level settlement tax |
| SSA + welfare administration (not benefits) |
~$100B across 89 programs |
UBI smart contract |
| GAO + IG offices |
~$1B+ |
Transparent ledger |
| CBO |
~$60M |
Optimocracy engine |
| OMB |
~$143M |
Wishocratic eigenvector |
| Census Bureau |
~$1.4B/year amortized |
Identity layer |
| Total public operating overhead |
~$123B/year |
|
Private compliance burn is larger but different in kind. Americans and firms spend $546 billion (95% CI: $450 billion-$650 billion) per year on tax compliance and $580 billion (95% CI: $290 billion-$1 trillion) per year on regulatory red tape. That value returns to households and firms as time back, fees not paid, and lower operating costs. It is real social gain, but it is not a Treasury pool and therefore is not counted in the routable UBI total.
Note what is not in this table: the benefit pools themselves. The conservative floor reported below excludes current welfare benefits to avoid mixing transfer replacement with waste removal. In the cash-maximal workable design, the transfer-like portion of those programs is collapsed into the UBI base rather than preserved as separate bureaucracies. What remains outside raw cash are only the pieces that are not actually transfers: catastrophic risk pooling, child-linked education funding, and incapacity management for citizens who cannot contract on their own behalf. The broader $1.2 trillion (95% CI: $1 trillion-$1.5 trillion) healthcare waste estimated in the US Efficiency Audit is still treated below as lower system cost, not as a fiscal windfall that can simply be deposited as cash.
The bank tollbooth. The US Efficiency Audit totals used in this paper count government waste. They do not include the private tollbooth created by the same monetary architecture. Finance and insurance captured 8% of US GDP in Q3 2025, about $2.3 trillion/year162. In the early 1970s the sector was about 4% of GDP162,163. The cleanest excess estimate is therefore the post-1971 doubling itself: roughly 4% of GDP, or about $1.1 trillion/year, before counting bailout tails, Cantillon gains, and politically protected spreads. That direction matches the micro evidence: Philippon and Reshef find that 30-50% of the finance wage premium is pure rent rather than payment for real complexity163. The full $2.3 trillion/year is the gross ceiling if deposits, payments, settlement, custody, and much of the current money-moving stack migrate to the protocol.
Not every institution currently called a bank disappears. Credit analysis, bankruptcy workouts, and duration matching remain real work. But those functions do not require banks to sit between every citizen and their money. The protocol removes banks as utilities and leaves only competitive lending businesses.
Lobbying-Purchased Policy Waste
The larger savings come not from eliminating agencies but from eliminating the policies those agencies were lobbied into maintaining. These policies persist because an intermediary (a politician, a regulator, a committee chair) was purchased, and the purchaser has a financial interest in the policy’s continuation:
This money is not “wasted” in the sense of vanishing. It goes to defense contractors, agricultural corporations, fossil fuel companies, and the prison-industrial complex. It is extracted from taxpayers and delivered to industries whose lobbying purchased the delivery. Remove the intermediary and the purchase has no seller. Under the protocol’s default fiscal rule, cash that is directly recaptured does not disappear into a lower nominal tax rate or get quietly reabsorbed by agencies. It is swept into the structural dividend and deposited equally as UBI. Visible cash is the default because visible cash is politically durable.
- Tax evasion recovery: The net tax gap is ~$600B/year. The protocol closes most of it through three reinforcing mechanisms. First, underreporting of on-ledger final consumption becomes far harder because settlement and tax collection occur in the same transaction. Second, the incentive to evade collapses: a low single-digit or low-double-digit settlement tax is far less worth evading than a 52% marginal rate (income + payroll combined). Third, UBI is conditional on verified on-ledger identity. Going off-ledger to avoid a small tax means forfeiting a daily cash deposit that often exceeds what you would save. Off-ledger activity (cash labor, barter, foreign settlement) will not disappear entirely, but the incentive structure shrinks it to a fraction of the current gap. Conservative estimate: ~$500B/year recovered.
Structural GDP Recovery
Some waste is not money spent badly but economic activity prevented entirely. The US Efficiency Audit157 estimates $1.56 trillion (95% CI: $1.05 trillion-$2.18 trillion)/year in policy-induced GDP loss recoverable at OECD-median performance:
No citizen, given the choice and the evidence, allocates funding to “make housing illegal where I need it.” But budget automation alone does not repeal law. The protocol handles that explicitly. When evidence shows that a rule destroys purchasing power or median income, citizens in the relevant jurisdiction vote on the rule directly; where the higher jurisdiction cannot directly repeal a lower-jurisdiction rule, funding flows are conditioned on compliance instead of pretending away federalism. Remove the intermediary from rulemaking as well as budgeting, and the suppressed economic activity resumes. This is not money freed up from a budget. It is economic growth that was being prevented and is no longer.
Where the Savings Flow
The accounting rule is simple. If the protocol directly captures the cash, it becomes UBI by default. If the protocol removes a cost without routing the money through the Treasury, the gain shows up as lower prices, lower fees, less compliance labor, or higher wages. Mixing those categories is how governance papers become sloppy.
| Agency operating overhead eliminated |
~$123B/year |
~$370/person |
Structural dividend (cash UBI) |
| Direct spending waste reclaimed |
$1.01 trillion (95% CI: $790 billion-$1.3 trillion)/year |
~$3,000/person |
Structural dividend (cash UBI) |
| Tax gap recovery |
~$500B/year |
~$1,500/person |
Structural dividend (cash UBI) |
| Total protocol-routable UBI floor |
~$1.63T/year |
~$4,900/person |
Deposited daily as equal cash |
| Compliance burden removed |
$1.13 trillion (95% CI: $775 billion-$1.58 trillion)/year |
~$3,400/person |
Time back, lower private costs, lower prices |
| Healthcare system waste removed |
$1.2 trillion (95% CI: $1 trillion-$1.45 trillion)/year |
~$3,600/person |
Lower healthcare prices, premiums, and tax pressure |
| GDP suppression reversed |
$1.56 trillion (95% CI: $1.05 trillion-$2.18 trillion)/year |
~$4,700/person |
Higher wages, more jobs, larger output |
| Financial intermediation rent removed (defensible excess estimate) |
~$1.1T/year |
~$3,300/person |
Lower fees and spreads, lower bailout risk, labor released from arbitrage |
| Total non-UBI societal gain |
~$4.99T/year |
~$14,900/person |
Cheaper life rather than a Treasury transfer |
| Combined conservative quantified total |
~$6.62T/year |
~$19,800/person |
Cash plus lower costs |
Using the full $2.3T/year finance capture instead of the $1.1T excess estimate raises the combined quantified total to roughly ~$7.82T/year, or about ~$23,400 per person. That is a ceiling, not the central claim.
The paper therefore makes two distinct promises. First, the protocol can plausibly deliver a visible structural dividend of roughly $4,900 per person per year before counting any productivity dividend or optional democratic supplement. Second, it can remove an additional ~$14,900 per person per year in diffuse societal extraction that people experience as cheaper life rather than as a government transfer.
That visible-cash figure is intentionally conservative. It counts waste removal and newly recoverable revenue, not the larger redesign step of collapsing existing transfer programs into the same cash rail. The United States already runs over $1.1 trillion/year in means-tested welfare through 89 federal programs. A maximum-workable UBI design would move the transfer-like portion of that spending into the UBI base, and over time do the same with retirement cash support, while leaving only catastrophic coverage, child-linked education vouchers, and narrow incapacity rules outside the universal cash stream. Those layers are not added to the floor here because existing budget aggregates mix cash transfers with service spending and would otherwise invite double counting.
These numbers should be read as a conservative floor, not as a full automation ceiling. Several plausible gains are intentionally excluded because they are real but not separately modeled cleanly enough yet:
- State and local duplication. The US Efficiency Audit explicitly excludes large parts of state and local administrative waste, even though licensing, permitting, property-tax administration, benefits administration, local compliance, and procurement are full of the same replaceable spreadsheet functions.
- Workflow automation not separately isolated. Grant administration, permit review, customs processing, procurement routing, claims handling, prior authorization, and other queue-based bureaucratic workflows are partly reflected inside broader categories like regulatory red tape, healthcare inefficiency, or military overspend, but are not broken out as standalone additions in this paper.
- Campaign-finance and lobbying overhead itself. The protocol removes much of the machinery that makes donor capture profitable, but the paper counts the resulting bad allocations, not the full standalone cost of the political compliance industry that services them.
If those layers were separately measured and added without overlap, the upside would be higher. They are left out here because a defensible floor is more useful than an inflated ceiling.
The adoption mechanism (how the protocol passes despite intermediary resistance) is funded through Incentive Alignment Bonds161, which align investor, politician, and citizen incentives. The financial architecture of adoption, including the bond structure, revenue splits, and political incentive mechanics, is specified in that paper. This paper describes what the protocol does. The IAB paper describes how it gets adopted.
Wishocracy governs the ordinary discretionary budget (the existing $6.8T in federal spending), not the protocol-captured savings stream. The protocol-captured savings flow to citizens by default as UBI. The ordinary budget is where citizens express preferences on cancer research vs. infrastructure vs. defense and other true public goods, while citizen rule votes govern legal changes that are not reducible to budget lines. The federal role is to finance the floor; states and localities should handle most service delivery and can top up the federal floor rather than recreate it.
The total is not double-counted. The US Efficiency Audit157 contributes four categories to the $4.9T base arithmetic: direct spending waste, compliance burden, policy-induced GDP loss, and system inefficiency. This paper then treats agency operating overhead, tax-gap recovery, and financial intermediation rent as adjacent categories outside that $4.9T base so that public waste, private toll extraction, and newly recoverable revenue are not blurred together.
What the Dividend Looks Like
Abstract trillions are difficult to feel. A structural dividend of ~$1.63T/year is not. That is roughly $4,900 per person per year, about $400/month per citizen, or roughly $19,500 per year for a family of four, before the productivity dividend and before any optional democratic supplement. Deposited daily, it is an always-visible reminder that the money used to go to intermediaries and now goes to citizens.
The rest of the gain is not imaginary or secondary. It simply arrives in a different form. The conservative non-UBI stack, roughly $14,900 per person per year, shows up as cheaper housing, cheaper healthcare, lower bank spreads, lower transaction fees, less filing labor, and higher wages from output that is no longer being suppressed. The protocol therefore improves household finances from both sides: more money in, less money stolen.
The current system cannot do this. Not because the money does not exist, but because the intermediaries who control it have no incentive to allocate it this way. The lobbying industry does not represent hungry children. Malaria does not have a Super PAC. Clean water does not make campaign contributions. The allocation reflects who has access to the intermediary, not who has the greatest need. Remove the intermediary, and the math changes. Not because citizens are saints. Because citizens, unlike intermediaries, are also the beneficiaries.
Implementation Pathway
The protocol cannot be deployed simultaneously. Each primitive has prerequisites, and trust must be earned, not assumed.
Phase 0: Evidence layer (deploy now). The Optimocracy engine160 and Optimal Budget Generator164 require no legislative change. They compare existing policy outcomes across jurisdictions and publish findings. This is research, not governance. Deployment: immediate.
Phase 1: Preference aggregation (deploy with treaty). The 1% Treaty165 159 creates the first pool of wishocratically allocated funds. Citizens allocate $27.2 billion/year via pairwise comparison. One funding stream, one mechanism, outcomes measured by the evidence layer. Deployment: concurrent with treaty ratification.
Phase 2: Transparency layer (Years 1-3). Treaty funds flow through a public ledger. Every allocation from wishocratic preference to final expenditure is visible. This demonstrates the accountability model at limited scale before extending it.
Phase 3: Identity and distribution (Years 3-7). The identity layer and UBI distribution require the largest infrastructure investment. India enrolled 1.4 billion people in Aadhaar using a camera, a fingerprint scanner, and the radical assumption that the government should know who lives there. Estonia runs an entire government digitally. The engineering works at national scale. Global scale requires coordination between national systems, not invention of new technology. Multiple approaches (biometric, social graph, zero-knowledge proof) are in production today.
Phase 4: Revenue and monetary policy (Years 7-15). Replacing the tax system and monetary policy requires the most political capital and the highest confidence in the protocol’s reliability. Deployed last, after Phases 0-3 have demonstrated the model at increasing scale.
Each phase is a test. If citizens allocate treaty funds better than committees do (Phase 1), the argument for letting them allocate domestic budgets gets harder to ignore. If the transparent ledger eliminates corruption in treaty spending (Phase 2), the argument for extending it to all government spending gets harder to ignore. The protocol earns trust by performing, not by promising.
Political Economy of Adoption
The protocol proposes to eliminate intermediaries. The intermediaries will not vote for their own elimination. This is not a flaw in the analysis. It is the central political problem, and ignoring it would make the paper useless.
The adoption pathway does not run through policymakers. It runs through citizens, who then apply pressure that policymakers cannot resist. The mechanism is the same one that passes the 1% Treaty159, funded through Incentive Alignment Bonds161 that align investor, politician, and citizen incentives through self-interest rather than altruism. The full financial architecture of adoption is specified in the IAB paper.
The citizen pitch is one sentence: “Your family loses roughly $79,000 per year to intermediation and financial tolls on the conservative numbers. This protocol gives you about $19,500 of that back as visible cash and the rest as lower prices, lower fees, and higher wages. Politicians oppose it because they are the intermediaries.”
That last sentence is the key. It reframes every objection as self-interested confirmation of the thesis. A politician who argues against the protocol is arguing for the system that costs each family roughly $79,000 on the conservative numbers. The argument against adoption is the argument for adoption.
Three incentive layers make adoption self-reinforcing:
Citizens want cash. Nobody needs to understand RAPPA or eigenvectors to understand “money in your account every morning.” Email adoption did not require understanding SMTP. The web did not require understanding TCP/IP. The governance improvements are infrastructure the user never sees. The cash is the product.
Investors want returns. The IABs make the protocol’s adoption and expansion directly profitable for bondholders, turning every investor into a permanent lobbyist. The greedier the investor, the harder they lobby.
Politicians want funding. The Citizen Alignment Score158 and IAB-funded political incentives make supporting the protocol more financially rewarding than opposing it. Politicians follow the money. They always do. The protocol redirects where the money points.
The result is a system where every participant acts selfishly and the protocol gets adopted anyway. This is not idealism. It is the same trick your species already uses for everything else. You call it “the market.” The same species that invented lobbying can be out-lobbied.
Objections
“You can’t replace human judgment with algorithms”
We are not replacing judgment. We are replacing arithmetic. The IRS does not exercise judgment when it calculates your tax liability. It executes a formula. The SSA does not exercise judgment when it computes your benefit amount. It applies a table. The Census Bureau does not exercise judgment when it counts people. It counts them. We propose that the formula execute itself, the table apply itself, and the count count itself. The functions that require actual judgment (criminal sentencing, disability determination, asylum adjudication) remain human. We are replacing the spreadsheet, not the courtroom.
“This is techno-utopianism”
The dishwasher replaced dishwashing. The ATM replaced the bank teller line. The spreadsheet replaced 400,000 bookkeepers. None of these were utopianism. All of them were obviously better at the specific function they replaced. The claim is not “algorithms will solve governance.” The claim is “algorithms will solve the specific functions that are already algorithmic but are being executed by millions of expensive, lobbyable humans.” This is the same category of claim as “dishwashers will solve dishes.” It is not ambitious. It is pedestrian.
“The transition would be chaotic”
The status quo is chaotic. Your government shuts down when 535 people cannot agree on a spreadsheet. Your tax system requires 6.1 billion hours of annual compliance labor. Your welfare system makes people wait months for benefits they need immediately. Your accountability system takes 18 months to audit spending that happened in real time. The protocol described in this paper is not a leap from order to chaos. It is a leap from expensive chaos to cheaper order.
The phased implementation ensures that each component demonstrates value before the next is deployed. Phase 1 allocates treaty funds only. If it fails, the cost is 1% of military spending, which is less than most militaries lose to procurement waste annually. If it succeeds, Phase 2 extends the model. At no point is the existing system retired before the replacement has proven itself.
“What about privacy?”
Government spending should be public by default. It is your money. The current system inverts this: your personal data is harvested and sold by private companies, while government spending is hidden behind FOIA requests that take months to years. The protocol reverses the asymmetry. Government transactions are public. Private consumer settlements reveal only the minimum fields needed for tax collection and macro accounting: amount, standardized category, jurisdiction, and time bucket. Identities, counterparties, and item-level receipts remain private and are validated with zero-knowledge proofs. You can see where every tax dollar goes. Nobody can see what you bought for lunch. This is the correct configuration. Yours is backwards.
Limitations
What Cannot Be Replaced
The protocol replaces mechanical functions. It does not replace:
- Enforcement. Algorithms cannot arrest people, conduct investigations, or exercise prosecutorial discretion. Police, courts, and prisons require human judgment (and reform, but that is a different paper).
- Diplomacy. International negotiation requires relationship-building, cultural understanding, and strategic ambiguity. Algorithms are bad at ambiguity by design.
- Adjudication. Judges interpret law in context. Edge cases require judgment that algorithms cannot reliably provide.
- Emergency response. Disasters require adaptive decision-making under uncertainty. Algorithms optimize logistics; humans decide priorities when assumptions break.
We do not claim this protocol solves governance. We claim it solves the spreadsheet. The spreadsheet is the part you are paying $4.9 trillion (95% CI: $3.62 trillion-$6.5 trillion) per year for.
Failure Modes
Algorithmic capture. If the algorithm’s parameters can be influenced by concentrated interests, the intermediary problem returns in different form. Mitigation: minimize the number of tunable knobs. Tax base, wallet classes, basket definition, update schedule, and vote thresholds are public constitutional parameters; changes require supermajority wishocratic approval, and the evidence engine independently verifies outcomes.
Identity attacks. If sybil-resistance fails, the entire system (UBI, voting weight, census) is compromised. This is the single highest-risk component, and also the one your species is worst at. You still cannot agree on what counts as an ID.
Goodhart’s Law. Optimizing for measurable metrics (median income, HALE) may degrade unmeasured outcomes. Mitigation: the evidence engine continuously expands its measurement set, and citizens can wishocratically fund measurement of outcomes they care about.
Transition disruption. The protocol displaces workers. This deserves honest arithmetic, not hand-waving.
The targeted agencies employ approximately 195,000 permanent staff (IRS ~100,000; SSA ~60,000; Federal Reserve ~24,000; Census Bureau ~4,000; GAO ~3,600; CBO, OMB, FEC ~1,100). Not all roles are mechanical; enforcement, IT transition, judgment-based functions, and oversight of the new systems remain human. Approximately 60-70% of roles in targeted agencies perform the deterministic functions the protocol replaces. That is roughly 115,000-135,000 displaced workers. For context, more Americans lost their jobs to the spreadsheet than would lose their jobs to this protocol. The spreadsheet did not offer a transition fund. The protocol does.
Average federal employee total compensation (salary plus benefits) is approximately $130,000 per year. The cost of paying every displaced worker their full compensation for one year while they retrain or find new employment:
~$15-18 billion. One year of full pay for every displaced worker.
Annual conservative quantified gain from the protocol: roughly ~$6.62T/year, of which ~$1.63T/year is directly routable cash and the rest arrives as lower prices, lower fees, and higher output.
The transition cost is roughly 1% of the direct cash floor and less than 0.3% of the full conservative quantified gain. You could pay every displaced worker for ten years of full salary and still retain the overwhelming majority of the annual benefit. The transition fund could also include retraining programs, early retirement packages for workers near retirement age, and priority placement in the human-judgment roles that remain (enforcement, oversight, adjudication). The total transition package, even if made extravagantly generous, would be a rounding error on the savings.
The political barrier is real: the people whose jobs are replaced by the protocol are the same people currently responsible for approving the protocol. This is not a novel problem (the horse industry opposed the automobile, the telegram industry opposed the telephone, bookkeepers opposed the spreadsheet). In each case, the transition cost was real and the displaced workers deserved support. In no case was the correct response “keep the horses.” The protocol’s phased implementation means displacement is gradual, not overnight, and the savings fund the transition before full deployment.
What We Do Not Know
The protocol assumes that citizen preferences, informed by evidence, produce better resource allocation than expert committees captured by donors. The evidence so far (participatory budgeting, Switzerland’s direct democracy, Estonia’s digital governance) is encouraging but has not been tested at this scale. The phased implementation is designed to generate this evidence incrementally, at bounded cost, before full deployment.
Conclusion
Government is expensive because it is intermediated. Every layer between citizen preference and public outcome extracts value and introduces distortion. The US Efficiency Audit alone identifies $4.9 trillion (95% CI: $3.62 trillion-$6.5 trillion) per year in intermediation waste. Once recovered tax gap and excess financial intermediation rent are included, the conservative quantified stack in this paper rises to roughly ~$6.62T/year.
This protocol does not replace governance. It replaces the mechanical functions that governance currently delegates to humans at extraordinary cost: calculating taxes, distributing benefits, allocating budgets, auditing expenditures, counting citizens, and managing the money supply. These functions are algorithmic in nature. Making them actual algorithms eliminates the intermediary cost while preserving (and expanding) democratic control over what those algorithms do.
The 1% Treaty159 provides both the funding mechanism and the initial deployment surface. Treaty funds, allocated wishocratically and tracked on a public ledger, serve as a bounded pilot. Success at treaty scale builds the evidence and political capital for expansion. Failure at treaty scale costs 1% of military spending, which is less than most militaries lose to administrative overhead annually.
The protocol exists to be forked and improved. The implementation described here is almost certainly wrong in important ways. What is not wrong is the observation that paying millions of humans to execute deterministic functions is an expensive way to avoid writing the code.
1.
NIH Common Fund. NIH pragmatic trials: Minimal funding despite 30x cost advantage.
NIH Common Fund: HCS Research Collaboratory https://commonfund.nih.gov/hcscollaboratory (2025)
The NIH Pragmatic Trials Collaboratory funds trials at $500K for planning phase, $1M/year for implementation-a tiny fraction of NIH’s budget. The ADAPTABLE trial cost $14 million for 15,076 patients (= $929/patient) versus $420 million for a similar traditional RCT (30x cheaper), yet pragmatic trials remain severely underfunded. PCORnet infrastructure enables real-world trials embedded in healthcare systems, but receives minimal support compared to basic research funding. Additional sources: https://commonfund.nih.gov/hcscollaboratory | https://pcornet.org/wp-content/uploads/2025/08/ADAPTABLE_Lay_Summary_21JUL2025.pdf | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604499/
.
2.
Cato Institute. Chance of dying from terrorism statistic.
Cato Institute: Terrorism and Immigration Risk Analysis https://www.cato.org/policy-analysis/terrorism-immigration-risk-analysis Chance of American dying in foreign-born terrorist attack: 1 in 3.6 million per year (1975-2015) Including 9/11 deaths; annual murder rate is 253x higher than terrorism death rate More likely to die from lightning strike than foreign terrorism Note: Comprehensive 41-year study shows terrorism risk is extremely low compared to everyday dangers Additional sources: https://www.cato.org/policy-analysis/terrorism-immigration-risk-analysis | https://www.nbcnews.com/news/us-news/you-re-more-likely-die-choking-be-killed-foreign-terrorists-n715141
.
3.
NIH. Antidepressant clinical trial exclusion rates.
Zimmerman et al. https://pubmed.ncbi.nlm.nih.gov/26276679/ (2015)
Mean exclusion rate: 86.1% across 158 antidepressant efficacy trials (range: 44.4% to 99.8%) More than 82% of real-world depression patients would be ineligible for antidepressant registration trials Exclusion rates increased over time: 91.4% (2010-2014) vs. 83.8% (1995-2009) Most common exclusions: comorbid psychiatric disorders, age restrictions, insufficient depression severity, medical conditions Emergency psychiatry patients: only 3.3% eligible (96.7% excluded) when applying 9 common exclusion criteria Only a minority of depressed patients seen in clinical practice are likely to be eligible for most AETs Note: Generalizability of antidepressant trials has decreased over time, with increasingly stringent exclusion criteria eliminating patients who would actually use the drugs in clinical practice Additional sources: https://pubmed.ncbi.nlm.nih.gov/26276679/ | https://pubmed.ncbi.nlm.nih.gov/26164052/ | https://www.wolterskluwer.com/en/news/antidepressant-trials-exclude-most-real-world-patients-with-depression
.
4.
CNBC. Warren buffett’s career average investment return.
CNBC https://www.cnbc.com/2025/05/05/warren-buffetts-return-tally-after-60-years-5502284percent.html (2025)
Berkshire’s compounded annual return from 1965 through 2024 was 19.9%, nearly double the 10.4% recorded by the S&P 500. Berkshire shares skyrocketed 5,502,284% compared to the S&P 500’s 39,054% rise during that period. Additional sources: https://www.cnbc.com/2025/05/05/warren-buffetts-return-tally-after-60-years-5502284percent.html | https://www.slickcharts.com/berkshire-hathaway/returns
.
5.
World Health Organization. WHO global health estimates 2024.
World Health Organization https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates (2024)
Comprehensive mortality and morbidity data by cause, age, sex, country, and year Global mortality: 55-60 million deaths annually Lives saved by modern medicine (vaccines, cardiovascular drugs, oncology): 12M annually (conservative aggregate) Leading causes of death: Cardiovascular disease (17.9M), Cancer (10.3M), Respiratory disease (4.0M) Note: Baseline data for regulatory mortality analysis. Conservative estimate of pharmaceutical impact based on WHO immunization data (4.5M/year from vaccines) + cardiovascular interventions (3.3M/year) + oncology (1.5M/year) + other therapies. Additional sources: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates
.
6.
GiveWell. GiveWell cost per life saved for top charities (2024).
GiveWell: Top Charities https://www.givewell.org/charities/top-charities General range: $3,000-$5,500 per life saved (GiveWell top charities) Helen Keller International (Vitamin A): $3,500 average (2022-2024); varies $1,000-$8,500 by country Against Malaria Foundation: $5,500 per life saved New Incentives (vaccination incentives): $4,500 per life saved Malaria Consortium (seasonal malaria chemoprevention): $3,500 per life saved VAS program details: $2 to provide vitamin A supplements to child for one year Note: Figures accurate for 2024. Helen Keller VAS program has wide country variation ($1K-$8.5K) but $3,500 is accurate average. Among most cost-effective interventions globally Additional sources: https://www.givewell.org/charities/top-charities | https://www.givewell.org/charities/helen-keller-international | https://ourworldindata.org/cost-effectiveness
.
7.
U.S. Department of Defense.
5.56mm NATO ammunition bulk procurement pricing. (2024)
The cost of 5.56mm NATO ammunition at military bulk procurement rates is approximately $0.40 per round, based on Lake City Army Ammunition Plant production and commercial market floor prices for mil-spec M855 ammunition.
8.
Pike, J.
U.s. Forces fire 250,000 rounds for every insurgent killed. (2011)
The General Accounting Office reports that US forces used 1.8 billion rounds of small-arms ammunition per year, a level that more than doubled in five years. An estimated 250,000 rounds were fired for every insurgent killed in Iraq and Afghanistan.
9.
AARP. Unpaid caregiver hours and economic value.
AARP 2023 https://www.aarp.org/caregiving/financial-legal/info-2023/unpaid-caregivers-provide-billions-in-care.html (2023)
Average family caregiver: 25-26 hours per week (100-104 hours per month) 38 million caregivers providing 36 billion hours of care annually Economic value: $16.59 per hour = $600 billion total annual value (2021) 28% of people provided eldercare on a given day, averaging 3.9 hours when providing care Caregivers living with care recipient: 37.4 hours per week Caregivers not living with recipient: 23.7 hours per week Note: Disease-related caregiving is subset of total; includes elderly care, disability care, and child care Additional sources: https://www.aarp.org/caregiving/financial-legal/info-2023/unpaid-caregivers-provide-billions-in-care.html | https://www.bls.gov/news.release/elcare.nr0.htm | https://www.caregiver.org/resource/caregiver-statistics-demographics/
.
10.
Forbes.
Forbes world’s billionaires list 2024. (2024)
Forbes identified a record 2,781 billionaires worldwide with combined net worth of $14.2 trillion, 141 more than 2023. Bernard Arnault (LVMH) topped the list at $233 billion.
11.
CDC MMWR. Childhood vaccination economic benefits.
CDC MMWR https://www.cdc.gov/mmwr/volumes/73/wr/mm7331a2.htm (1994)
US programs (1994-2023): $540B direct savings, $2.7T societal savings ( $18B/year direct, $90B/year societal) Global (2001-2020): $820B value for 10 diseases in 73 countries ( $41B/year) ROI: $11 return per $1 invested Measles vaccination alone saved 93.7M lives (61% of 154M total) over 50 years (1974-2024) Additional sources: https://www.cdc.gov/mmwr/volumes/73/wr/mm7331a2.htm | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00850-X/fulltext
.
15.
U.S. Bureau of Labor Statistics.
CPI inflation calculator. (2024)
CPI-U (1980): 82.4 CPI-U (2024): 313.5 Inflation multiplier (1980-2024): 3.80× Cumulative inflation: 280.48% Average annual inflation rate: 3.08% Note: Official U.S. government inflation data using Consumer Price Index for All Urban Consumers (CPI-U). Additional sources: https://www.bls.gov/data/inflation_calculator.htm
.
16.
James Surowiecki.
The Wisdom of Crowds. (Surowiecki, 2004).
Explores the aggregation of information in groups, arguing that decisions are often better than could have been made by any single member of the group. The opening anecdote relates Francis Galton’s surprise that the crowd at a county fair accurately guessed the weight of an ox when the median of their individual guesses was taken. The three conditions for a group to be intelligent are diversity, independence, and decentralization. Additional sources: https://archive.org/details/wisdomofcrowds0000suro | https://en.wikipedia.org/wiki/The_Wisdom_of_Crowds | https://www.amazon.com/Wisdom-Crowds-James-Surowiecki/dp/0385721706
.
17.
ClinicalTrials.gov API v2 direct analysis. ClinicalTrials.gov cumulative enrollment data (2025).
Direct analysis via ClinicalTrials.gov API v2 https://clinicaltrials.gov/data-api/api Analysis of 100,000 active/recruiting/completed trials on ClinicalTrials.gov (as of January 2025) shows cumulative enrollment of 12.2 million participants: Phase 1 (722k), Phase 2 (2.2M), Phase 3 (6.5M), Phase 4 (2.7M). Median participants per trial: Phase 1 (33), Phase 2 (60), Phase 3 (237), Phase 4 (90). Additional sources: https://clinicaltrials.gov/data-api/api
.
18.
ACS CAN. Clinical trial patient participation rate.
ACS CAN: Barriers to Clinical Trial Enrollment https://www.fightcancer.org/policy-resources/barriers-patient-enrollment-therapeutic-clinical-trials-cancer Only 3-5% of adult cancer patients in US receive treatment within clinical trials About 5% of American adults have ever participated in any clinical trial Oncology: 2-3% of all oncology patients participate Contrast: 50-60% enrollment for pediatric cancer trials (<15 years old) Note: 20% of cancer trials fail due to insufficient enrollment; 11% of research sites enroll zero patients Additional sources: https://www.fightcancer.org/policy-resources/barriers-patient-enrollment-therapeutic-clinical-trials-cancer | https://hints.cancer.gov/docs/Briefs/HINTS_Brief_48.pdf
.
19.
ScienceDaily. Global prevalence of chronic disease.
ScienceDaily: GBD 2015 Study https://www.sciencedaily.com/releases/2015/06/150608081753.htm (2015)
2.3 billion individuals had more than five ailments (2013) Chronic conditions caused 74% of all deaths worldwide (2019), up from 67% (2010) Approximately 1 in 3 adults suffer from multiple chronic conditions (MCCs) Risk factor exposures: 2B exposed to biomass fuel, 1B to air pollution, 1B smokers Projected economic cost: $47 trillion by 2030 Note: 2.3B with 5+ ailments is more accurate than "2B with chronic disease." One-third of all adults globally have multiple chronic conditions Additional sources: https://www.sciencedaily.com/releases/2015/06/150608081753.htm | https://pmc.ncbi.nlm.nih.gov/articles/PMC10830426/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC6214883/
.
20.
C&EN. Annual number of new drugs approved globally: 50.
C&EN https://cen.acs.org/pharmaceuticals/50-new-drugs-received-FDA/103/i2 (2025)
50 new drugs approved annually Additional sources: https://cen.acs.org/pharmaceuticals/50-new-drugs-received-FDA/103/i2 | https://www.fda.gov/drugs/development-approval-process-drugs/novel-drug-approvals-fda
.
21.
Williams, R. J., Tse, T., DiPiazza, K. & Zarin, D. A.
Terminated trials in the ClinicalTrials.gov results database: Evaluation of availability of primary outcome data and reasons for termination.
PLOS One 10, e0127242 (2015)
Approximately 12% of trials with results posted on the ClinicalTrials.gov results database (905/7,646) were terminated. Primary reasons: insufficient accrual (57% of non-data-driven terminations), business/strategic reasons, and efficacy/toxicity findings (21% data-driven terminations).
25.
Rummel, R. J.
Death by Government: Genocide and Mass Murder Since 1900. (Transaction Publishers, 1994).
Political scientist R.J. Rummel’s comprehensive accounting of democide (government murder of unarmed civilians) in the 20th century. His final revised estimate: 262 million people murdered by their own governments from 1900-1999, excluding battle deaths in wars. Range: 200-272+ million. Communist regimes account for the largest share (100-148+ million). Updated figures at hawaii.edu/powerkills.
26.
GiveWell. Cost per DALY for deworming programs.
https://www.givewell.org/international/technical/programs/deworming/cost-effectiveness Schistosomiasis treatment: $28.19-$70.48 per DALY (using arithmetic means with varying disability weights) Soil-transmitted helminths (STH) treatment: $82.54 per DALY (midpoint estimate) Note: GiveWell explicitly states this 2011 analysis is "out of date" and their current methodology focuses on long-term income effects rather than short-term health DALYs Additional sources: https://www.givewell.org/international/technical/programs/deworming/cost-effectiveness
.
27.
Calculated from IHME Global Burden of Disease (2.55B DALYs) and global GDP per capita valuation. $109 trillion annual global disease burden.
The global economic burden of disease, including direct healthcare costs ($8.2 trillion) and lost productivity ($100.9 trillion from 2.55 billion DALYs × $39,570 per DALY), totals approximately $109.1 trillion annually.
29.
Think by Numbers. Pre-1962 drug development costs and timeline (think by numbers).
Think by Numbers: How Many Lives Does FDA Save? https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/ (1962)
Historical estimates (1970-1985): USD $226M fully capitalized (2011 prices) 1980s drugs: $65M after-tax R&D (1990 dollars), $194M compounded to approval (1990 dollars) Modern comparison: $2-3B costs, 7-12 years (dramatic increase from pre-1962) Context: 1962 regulatory clampdown reduced new treatment production by 70%, dramatically increasing development timelines and costs Note: Secondary source; less reliable than Congressional testimony Additional sources: https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/ | https://en.wikipedia.org/wiki/Cost_of_drug_development | https://www.statnews.com/2018/10/01/changing-1962-law-slash-drug-prices/
.
30.
Biotechnology Innovation Organization (BIO). BIO clinical development success rates 2011-2020.
Biotechnology Innovation Organization (BIO) https://go.bio.org/rs/490-EHZ-999/images/ClinicalDevelopmentSuccessRates2011_2020.pdf (2021)
Phase I duration: 2.3 years average Total time to market (Phase I-III + approval): 10.5 years average Phase transition success rates: Phase I→II: 63.2%, Phase II→III: 30.7%, Phase III→Approval: 58.1% Overall probability of approval from Phase I: 12% Note: Largest publicly available study of clinical trial success rates. Efficacy lag = 10.5 - 2.3 = 8.2 years post-safety verification. Additional sources: https://go.bio.org/rs/490-EHZ-999/images/ClinicalDevelopmentSuccessRates2011_2020.pdf
.
31.
Nature Medicine. Drug repurposing rate ( 30%).
Nature Medicine https://www.nature.com/articles/s41591-024-03233-x (2024)
Approximately 30% of drugs gain at least one new indication after initial approval. Additional sources: https://www.nature.com/articles/s41591-024-03233-x
.
32.
EPI. Education investment economic multiplier (2.1).
EPI: Public Investments Outside Core Infrastructure https://www.epi.org/publication/bp348-public-investments-outside-core-infrastructure/ Early childhood education: Benefits 12X outlays by 2050; $8.70 per dollar over lifetime Educational facilities: $1 spent → $1.50 economic returns Energy efficiency comparison: 2-to-1 benefit-to-cost ratio (McKinsey) Private return to schooling: 9% per additional year (World Bank meta-analysis) Note: 2.1 multiplier aligns with benefit-to-cost ratios for educational infrastructure/energy efficiency. Early childhood education shows much higher returns (12X by 2050) Additional sources: https://www.epi.org/publication/bp348-public-investments-outside-core-infrastructure/ | https://documents1.worldbank.org/curated/en/442521523465644318/pdf/WPS8402.pdf | https://freopp.org/whitepapers/establishing-a-practical-return-on-investment-framework-for-education-and-skills-development-to-expand-economic-opportunity/
.
33.
PMC. Healthcare investment economic multiplier (1.8).
PMC: California Universal Health Care https://pmc.ncbi.nlm.nih.gov/articles/PMC5954824/ (2022)
Healthcare fiscal multiplier: 4.3 (95% CI: 2.5-6.1) during pre-recession period (1995-2007) Overall government spending multiplier: 1.61 (95% CI: 1.37-1.86) Why healthcare has high multipliers: No effect on trade deficits (spending stays domestic); improves productivity & competitiveness; enhances long-run potential output Gender-sensitive fiscal spending (health & care economy) produces substantial positive growth impacts Note: "1.8" appears to be conservative estimate; research shows healthcare multipliers of 4.3 Additional sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC5954824/ | https://cepr.org/voxeu/columns/government-investment-and-fiscal-stimulus | https://ncbi.nlm.nih.gov/pmc/articles/PMC3849102/ | https://set.odi.org/wp-content/uploads/2022/01/Fiscal-multipliers-review.pdf
.
34.
World Bank. Infrastructure investment economic multiplier (1.6).
World Bank: Infrastructure Investment as Stimulus https://blogs.worldbank.org/en/ppps/effectiveness-infrastructure-investment-fiscal-stimulus-what-weve-learned (2022)
Infrastructure fiscal multiplier: 1.6 during contractionary phase of economic cycle Average across all economic states: 1.5 (meaning $1 of public investment → $1.50 of economic activity) Time horizon: 0.8 within 1 year, 1.5 within 2-5 years Range of estimates: 1.5-2.0 (following 2008 financial crisis & American Recovery Act) Italian public construction: 1.5-1.9 multiplier US ARRA: 0.4-2.2 range (differential impacts by program type) Economic Policy Institute: Uses 1.6 for infrastructure spending (middle range of estimates) Note: Public investment less likely to crowd out private activity during recessions; particularly effective when monetary policy loose with near-zero rates Additional sources: https://blogs.worldbank.org/en/ppps/effectiveness-infrastructure-investment-fiscal-stimulus-what-weve-learned | https://www.gihub.org/infrastructure-monitor/insights/fiscal-multiplier-effect-of-infrastructure-investment/ | https://cepr.org/voxeu/columns/government-investment-and-fiscal-stimulus | https://www.richmondfed.org/publications/research/economic_brief/2022/eb_22-04
.
35.
Mercatus. Military spending economic multiplier (0.6).
Mercatus: Defense Spending and Economy https://www.mercatus.org/research/research-papers/defense-spending-and-economy Ramey (2011): 0.6 short-run multiplier Barro (1981): 0.6 multiplier for WWII spending (war spending crowded out 40¢ private economic activity per federal dollar) Barro & Redlick (2011): 0.4 within current year, 0.6 over two years; increased govt spending reduces private-sector GDP portions General finding: $1 increase in deficit-financed federal military spending = less than $1 increase in GDP Variation by context: Central/Eastern European NATO: 0.6 on impact, 1.5-1.6 in years 2-3, gradual fall to zero Ramey & Zubairy (2018): Cumulative 1% GDP increase in military expenditure raises GDP by 0.7% Additional sources: https://www.mercatus.org/research/research-papers/defense-spending-and-economy | https://cepr.org/voxeu/columns/world-war-ii-america-spending-deficits-multipliers-and-sacrifice | https://www.rand.org/content/dam/rand/pubs/research_reports/RRA700/RRA739-2/RAND_RRA739-2.pdf
.
36.
FDA. FDA-approved prescription drug products (20,000+).
FDA https://www.fda.gov/media/143704/download There are over 20,000 prescription drug products approved for marketing. Additional sources: https://www.fda.gov/media/143704/download
.
38.
ACLED. Active combat deaths annually.
ACLED: Global Conflict Surged 2024 https://acleddata.com/2024/12/12/data-shows-global-conflict-surged-in-2024-the-washington-post/ (2024)
2024: 233,597 deaths (30% increase from 179,099 in 2023) Deadliest conflicts: Ukraine (67,000), Palestine (35,000) Nearly 200,000 acts of violence (25% higher than 2023, double from 5 years ago) One in six people globally live in conflict-affected areas Additional sources: https://acleddata.com/2024/12/12/data-shows-global-conflict-surged-in-2024-the-washington-post/ | https://acleddata.com/media-citation/data-shows-global-conflict-surged-2024-washington-post | https://acleddata.com/conflict-index/index-january-2024/
.
39.
UCDP. State violence deaths annually.
UCDP: Uppsala Conflict Data Program https://ucdp.uu.se/ Uppsala Conflict Data Program (UCDP): Tracks one-sided violence (organized actors attacking unarmed civilians) UCDP definition: Conflicts causing at least 25 battle-related deaths in calendar year 2023 total organized violence: 154,000 deaths; Non-state conflicts: 20,900 deaths UCDP collects data on state-based conflicts, non-state conflicts, and one-sided violence Specific "2,700 annually" figure for state violence not found in recent UCDP data; actual figures vary annually Additional sources: https://ucdp.uu.se/ | https://en.wikipedia.org/wiki/Uppsala_Conflict_Data_Program | https://ourworldindata.org/grapher/deaths-in-armed-conflicts-by-region
.
40.
Our World in Data. Terror attack deaths (8,300 annually).
Our World in Data: Terrorism https://ourworldindata.org/terrorism (2024)
2023: 8,352 deaths (22% increase from 2022, highest since 2017) 2023: 3,350 terrorist incidents (22% decrease), but 56% increase in avg deaths per attack Global Terrorism Database (GTD): 200,000+ terrorist attacks recorded (2021 version) Maintained by: National Consortium for Study of Terrorism & Responses to Terrorism (START), U. of Maryland Geographic shift: Epicenter moved from Middle East to Central Sahel (sub-Saharan Africa) - now >50% of all deaths Additional sources: https://ourworldindata.org/terrorism | https://reliefweb.int/report/world/global-terrorism-index-2024 | https://www.start.umd.edu/gtd/ | https://ourworldindata.org/grapher/fatalities-from-terrorism
.
41.
Institute for Health Metrics and Evaluation (IHME). IHME global burden of disease 2021 (2.88B DALYs, 1.13B YLD).
Institute for Health Metrics and Evaluation (IHME) https://vizhub.healthdata.org/gbd-results/ (2024)
In 2021, global DALYs totaled approximately 2.88 billion, comprising 1.75 billion Years of Life Lost (YLL) and 1.13 billion Years Lived with Disability (YLD). This represents a 13% increase from 2019 (2.55B DALYs), largely attributable to COVID-19 deaths and aging populations. YLD accounts for approximately 39% of total DALYs, reflecting the substantial burden of non-fatal chronic conditions. Additional sources: https://vizhub.healthdata.org/gbd-results/ | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00757-8/fulltext | https://www.healthdata.org/research-analysis/about-gbd
.
42.
Costs of War Project, Brown University Watson Institute. Environmental cost of war ($100B annually).
Brown Watson Costs of War: Environmental Cost https://watson.brown.edu/costsofwar/costs/social/environment War on Terror emissions: 1.2B metric tons GHG (equivalent to 257M cars/year) Military: 5.5% of global GHG emissions (2X aviation + shipping combined) US DoD: World’s single largest institutional oil consumer, 47th largest emitter if nation Cleanup costs: $500B+ for military contaminated sites Gaza war environmental damage: $56.4B; landmine clearance: $34.6B expected Climate finance gap: Rich nations spend 30X more on military than climate finance Note: Military activities cause massive environmental damage through GHG emissions, toxic contamination, and long-term cleanup costs far exceeding current climate finance commitments Additional sources: https://watson.brown.edu/costsofwar/costs/social/environment | https://earth.org/environmental-costs-of-wars/ | https://transformdefence.org/transformdefence/stats/
.
43.
ScienceDaily. Medical research lives saved annually (4.2 million).
ScienceDaily: Physical Activity Prevents 4M Deaths https://www.sciencedaily.com/releases/2020/06/200617194510.htm (2020)
Physical activity: 3.9M early deaths averted annually worldwide (15% lower premature deaths than without) COVID vaccines (2020-2024): 2.533M deaths averted, 14.8M life-years preserved; first year alone: 14.4M deaths prevented Cardiovascular prevention: 3 interventions could delay 94.3M deaths over 25 years (antihypertensives alone: 39.4M) Pandemic research response: Millions of deaths averted through rapid vaccine/drug development Additional sources: https://www.sciencedaily.com/releases/2020/06/200617194510.htm | https://pmc.ncbi.nlm.nih.gov/articles/PMC9537923/ | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038160 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9464102/
.
44.
SIPRI. 36:1 disparity ratio of spending on weapons over cures.
SIPRI: Military Spending https://www.sipri.org/commentary/blog/2016/opportunity-cost-world-military-spending (2016)
Global military spending: $2.7 trillion (2024, SIPRI) Global government medical research: $68 billion (2024) Actual ratio: 39.7:1 in favor of weapons over medical research Military R&D alone: $85B (2004 data, 10% of global R&D) Military spending increases crowd out health: 1% ↑ military = 0.62% ↓ health spending Note: Ratio actually worse than 36:1. Each 1% increase in military spending reduces health spending by 0.62%, with effect more intense in poorer countries (0.962% reduction) Additional sources: https://www.sipri.org/commentary/blog/2016/opportunity-cost-world-military-spending | https://pmc.ncbi.nlm.nih.gov/articles/PMC9174441/ | https://www.congress.gov/crs-product/R45403
.
45.
Think by Numbers. Lost human capital due to war ($270B annually).
Think by Numbers https://thinkbynumbers.org/military/war/the-economic-case-for-peace-a-comprehensive-financial-analysis/ (2021)
Lost human capital from war: $300B annually (economic impact of losing skilled/productive individuals to conflict) Broader conflict/violence cost: $14T/year globally 1.4M violent deaths/year; conflict holds back economic development, causes instability, widens inequality, erodes human capital 2002: 48.4M DALYs lost from 1.6M violence deaths = $151B economic value (2000 USD) Economic toll includes: commodity prices, inflation, supply chain disruption, declining output, lost human capital Additional sources: https://thinkbynumbers.org/military/war/the-economic-case-for-peace-a-comprehensive-financial-analysis/ | https://www.weforum.org/stories/2021/02/war-violence-costs-each-human-5-a-day/ | https://pubmed.ncbi.nlm.nih.gov/19115548/
.
46.
PubMed. Psychological impact of war cost ($100B annually).
PubMed: Economic Burden of PTSD https://pubmed.ncbi.nlm.nih.gov/35485933/ PTSD economic burden (2018 U.S.): $232.2B total ($189.5B civilian, $42.7B military) Civilian costs driven by: Direct healthcare ($66B), unemployment ($42.7B) Military costs driven by: Disability ($17.8B), direct healthcare ($10.1B) Exceeds costs of other mental health conditions (anxiety, depression) War-exposed populations: 2-3X higher rates of anxiety, depression, PTSD; women and children most vulnerable Note: Actual burden $232B, significantly higher than "$100B" claimed Additional sources: https://pubmed.ncbi.nlm.nih.gov/35485933/ | https://news.va.gov/103611/study-national-economic-burden-of-ptsd-staggering/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC9957523/
.
47.
CGDev. UNHCR average refugee support cost.
CGDev https://www.cgdev.org/blog/costs-hosting-refugees-oecd-countries-and-why-uk-outlier (2024)
The average cost of supporting a refugee is $1,384 per year. This represents total host country costs (housing, healthcare, education, security). OECD countries average $6,100 per refugee (mean 2022-2023), with developing countries spending $700-1,000. Global weighted average of $1,384 is reasonable given that 75-85% of refugees are in low/middle-income countries. Additional sources: https://www.cgdev.org/blog/costs-hosting-refugees-oecd-countries-and-why-uk-outlier | https://www.unhcr.org/sites/default/files/2024-11/UNHCR-WB-global-cost-of-refugee-inclusion-in-host-country-health-systems.pdf
.
48.
World Bank. World bank trade disruption cost from conflict.
World Bank https://www.worldbank.org/en/topic/trade/publication/trading-away-from-conflict Estimated $616B annual cost from conflict-related trade disruption. World Bank research shows civil war costs an average developing country 30 years of GDP growth, with 20 years needed for trade to return to pre-war levels. Trade disputes analysis shows tariff escalation could reduce global exports by up to $674 billion. Additional sources: https://www.worldbank.org/en/topic/trade/publication/trading-away-from-conflict | https://www.nber.org/papers/w11565 | http://blogs.worldbank.org/en/trade/impacts-global-trade-and-income-current-trade-disputes
.
49.
VA. Veteran healthcare cost projections.
VA https://department.va.gov/wp-content/uploads/2025/06/2026-Budget-in-Brief.pdf (2026)
VA budget: $441.3B requested for FY 2026 (10% increase). Disability compensation: $165.6B in FY 2024 for 6.7M veterans. PACT Act projected to increase spending by $300B between 2022-2031. Costs under Toxic Exposures Fund: $20B (2024), $30.4B (2025), $52.6B (2026). Additional sources: https://department.va.gov/wp-content/uploads/2025/06/2026-Budget-in-Brief.pdf | https://www.cbo.gov/publication/45615 | https://www.legion.org/information-center/news/veterans-healthcare/2025/june/va-budget-tops-400-billion-for-2025-from-higher-spending-on-mandated-benefits-medical-care
.
52.
Cybersecurity Ventures. Cybercrime economy projected to reach $10.5 trillion.
Cybersecurity Ventures: $10.5T Cybercrime https://cybersecurityventures.com/hackerpocalypse-cybercrime-report-2016/ (2016)
Global cybercrime costs: $3T (2015) → $6T (2021) → $10.5T (2025 projected) 15% annual growth rate If measured as country, would be 3rd largest economy after US and China Greatest transfer of economic wealth in history Note: More profitable than global trade of all major illegal drugs combined. Includes data theft, productivity loss, IP theft, fraud Additional sources: <https://cybersecurityventures.com/hackerpocalypse-cybercrime-report-2016/> | https://www.boisestate.edu/cybersecurity/2022/06/16/cybercrime-to-cost-the-world-10-5-trillion-annually-by-2025/
.
54.
Bolt, J. & Zanden, J. L. van.
Maddison project database 2020. (2020)
Historical GDP per capita estimates from year 1 to present. Global GDP per capita in 1900: approximately 1,260 in 1990 international dollars (roughly 3,150 in 2024 USD after PPP and inflation adjustment). Standard reference for long-run comparative economic history.
55.
Applied Clinical Trials. Global government spending on interventional clinical trials: $3-6 billion/year.
Applied Clinical Trials https://www.appliedclinicaltrialsonline.com/view/sizing-clinical-research-market Estimated range based on NIH ( $0.8-5.6B), NIHR ($1.6B total budget), and EU funding ( $1.3B/year). Roughly 5-10% of global market. Additional sources: https://www.appliedclinicaltrialsonline.com/view/sizing-clinical-research-market | https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30357-0/fulltext
.
59.
United Nations Department of Economic and Social Affairs, Population Division.
World population prospects 2024: Summary of results. (2024)
The 2024 Revision of the World Population Prospects provides population estimates and projections for 237 countries or areas. Global median age approximately 30.5 years in 2024, reflecting population-weighted average across all regions.
62.
Estimated from major foundation budgets and activities. Nonprofit clinical trial funding estimate.
Nonprofit foundations spend an estimated $2-5 billion annually on clinical trials globally, representing approximately 2-5% of total clinical trial spending.
63.
ICAN. Global nuclear weapon maintenance cost: $100 billion/year.
ICAN: Global Spending $100B 2024 https://www.icanw.org/global_spending_on_nuclear_weapons_topped_100_billion_in_2024 (2024)
2024: >$100 billion ($190,151/minute) - 11% increase ($9.9B) from 2023 Nine nuclear-armed states: China, France, India, Israel, N. Korea, Pakistan, Russia, UK, US US: $56.8B (more than all other 8 states combined); China: $12.5B; UK: $10B (+26% YoY, biggest increase) Historical trend: $72.9B (2019) → $82.4B (2021) → >$100B (2024) Private sector contracts: $463B ongoing; $42.5B earned from contracts in 2024 alone Note: $100B/year figure accurate for 2024. Rapid growth from $73B (2019). US spends more than rest of world combined on nuclear weapons Additional sources: https://www.icanw.org/global_spending_on_nuclear_weapons_topped_100_billion_in_2024 | https://www.icanw.org/the_cost_of_nuclear_weapons
.
64.
Industry reports: IQVIA. Global pharmaceutical r&d spending.
Total global pharmaceutical R&D spending is approximately $300 billion annually. Clinical trials represent 15-20% of this total ($45-60B), with the remainder going to drug discovery, preclinical research, regulatory affairs, and manufacturing development.
65.
UN. Global population reaches 8 billion.
UN: World Population 8 Billion Nov 15 2022 https://www.un.org/en/desa/world-population-reach-8-billion-15-november-2022 (2022)
Milestone: November 15, 2022 (UN World Population Prospects 2022) Day of Eight Billion" designated by UN Added 1 billion people in just 11 years (2011-2022) Growth rate: Slowest since 1950; fell under 1% in 2020 Future: 15 years to reach 9B (2037); projected peak 10.4B in 2080s Projections: 8.5B (2030), 9.7B (2050), 10.4B (2080-2100 plateau) Note: Milestone reached Nov 2022. Population growth slowing; will take longer to add next billion (15 years vs 11 years) Additional sources: https://www.un.org/en/desa/world-population-reach-8-billion-15-november-2022 | https://www.un.org/en/dayof8billion | https://en.wikipedia.org/wiki/Day_of_Eight_Billion
.
66.
Harvard Kennedy School. 3.5% participation tipping point.
Harvard Kennedy School https://www.hks.harvard.edu/centers/carr/publications/35-rule-how-small-minority-can-change-world (2020)
The research found that nonviolent campaigns were twice as likely to succeed as violent ones, and once 3.5% of the population were involved, they were always successful. Chenoweth and Maria Stephan studied the success rates of civil resistance efforts from 1900 to 2006, finding that nonviolent movements attracted, on average, four times as many participants as violent movements and were more likely to succeed. Key finding: Every campaign that mobilized at least 3.5% of the population in sustained protest was successful (in their 1900-2006 dataset) Note: The 3.5% figure is a descriptive statistic from historical analysis, not a guaranteed threshold. One exception (Bahrain 2011-2014 with 6%+ participation) has been identified. The rule applies to regime change, not policy change in democracies. Additional sources: https://www.hks.harvard.edu/centers/carr/publications/35-rule-how-small-minority-can-change-world | https://www.hks.harvard.edu/sites/default/files/2024-05/Erica%20Chenoweth_2020-005.pdf | https://www.bbc.com/future/article/20190513-it-only-takes-35-of-people-to-change-the-world | https://en.wikipedia.org/wiki/3.5%25_rule
.
67.
International IDEA.
International IDEA voter turnout database world export. (2026)
Best current register-based estimate of global registered voters. Sum of the latest available country-level Registration counts in International IDEA’s world export on 2026-04-22 = 4,128,142,495 registered voters across 199 countries and political entities. Methodology notes that Registration is the number of names on the voters’ register as reported by electoral management bodies, and comparability is imperfect because voter rolls and registration systems differ across countries. Additional sources: https://www.idea.int/data-tools/data/voter-turnout-database | https://www.idea.int/data-tools/export?type=region_only&themeId=293&world=all&loc=home
.
69.
Federation of American Scientists. World nuclear forces.
Federation of American Scientists https://fas.org/issues/nuclear-weapons/status-world-nuclear-forces/ (2024)
As of early 2025, we estimate that the world’s nine nuclear-armed states possess a combined total of approximately 12,241 nuclear warheads. Additional sources: https://fas.org/issues/nuclear-weapons/status-world-nuclear-forces/
.
70.
NHGRI. Human genome project and CRISPR discovery.
NHGRI https://www.genome.gov/11006929/2003-release-international-consortium-completes-hgp (2003)
Your DNA is 3 billion base pairs Read the entire code (Human Genome Project, completed 2003) Learned to edit it (CRISPR, discovered 2012) Additional sources: https://www.genome.gov/11006929/2003-release-international-consortium-completes-hgp | https://www.nobelprize.org/prizes/chemistry/2020/press-release/
.
71.
PMC. Only 12% of human interactome targeted.
PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC10749231/ (2023)
Mapping 350,000+ clinical trials showed that only 12% of the human interactome has ever been targeted by drugs. Additional sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10749231/
.
72.
WHO. ICD-10 code count ( 14,000).
WHO https://icd.who.int/browse10/2019/en (2019)
The ICD-10 classification contains approximately 14,000 codes for diseases, signs and symptoms. Additional sources: https://icd.who.int/browse10/2019/en
.
73.
Wikipedia. Longevity escape velocity (LEV) - maximum human life extension potential.
Wikipedia: Longevity Escape Velocity https://en.wikipedia.org/wiki/Longevity_escape_velocity Longevity escape velocity: Hypothetical point where medical advances extend life expectancy faster than time passes Term coined by Aubrey de Grey (biogerontologist) in 2004 paper; concept from David Gobel (Methuselah Foundation) Current progress: Science adds 3 months to lifespan per year; LEV requires adding >1 year per year Sinclair (Harvard): "There is no biological upper limit to age" - first person to live to 150 may already be born De Grey: 50% chance of reaching LEV by mid-to-late 2030s; SENS approach = damage repair rather than slowing damage Kurzweil (2024): LEV by 2029-2035, AI will simulate biological processes to accelerate solutions George Church: LEV "in a decade or two" via age-reversal clinical trials Natural lifespan cap: 120-150 years (Jeanne Calment record: 122); engineering approach could bypass via damage repair Key mechanisms: Epigenetic reprogramming, senolytic drugs, stem cell therapy, gene therapy, AI-driven drug discovery Current record: Jeanne Calment (122 years, 164 days) - record unbroken since 1997 Note: LEV is theoretical but increasingly plausible given demonstrated age reversal in mice (109% lifespan extension) and human cells (30-year epigenetic age reversal) Additional sources: https://en.wikipedia.org/wiki/Longevity_escape_velocity | https://pmc.ncbi.nlm.nih.gov/articles/PMC423155/ | https://www.popularmechanics.com/science/a36712084/can-science-cure-death-longevity/ | https://www.diamandis.com/blog/longevity-escape-velocity
.
74.
OpenSecrets. Lobbyist statistics for washington d.c.
OpenSecrets: Lobbying in US https://en.wikipedia.org/wiki/Lobbying_in_the_United_States Registered lobbyists: Over 12,000 (some estimates); 12,281 registered (2013) Former government employees as lobbyists: 2,200+ former federal employees (1998-2004), including 273 former White House staffers, 250 former Congress members & agency heads Congressional revolving door: 43% (86 of 198) lawmakers who left 1998-2004 became lobbyists; currently 59% leaving to private sector work for lobbying/consulting firms/trade groups Executive branch: 8% were registered lobbyists at some point before/after government service Additional sources: https://en.wikipedia.org/wiki/Lobbying_in_the_United_States | https://www.opensecrets.org/revolving-door | https://www.citizen.org/article/revolving-congress/ | https://www.propublica.org/article/we-found-a-staggering-281-lobbyists-whove-worked-in-the-trump-administration
.
75.
MDPI Vaccines. Measles vaccination ROI.
MDPI Vaccines https://www.mdpi.com/2076-393X/12/11/1210 (2024)
Single measles vaccination: 167:1 benefit-cost ratio. MMR (measles-mumps-rubella) vaccination: 14:1 ROI. Historical US elimination efforts (1966-1974): benefit-cost ratio of 10.3:1 with net benefits exceeding USD 1.1 billion (1972 dollars, or USD 8.0 billion in 2023 dollars). 2-dose MMR programs show direct benefit/cost ratio of 14.2 with net savings of $5.3 billion, and 26.0 from societal perspectives with net savings of $11.6 billion. Additional sources: https://www.mdpi.com/2076-393X/12/11/1210 | https://www.tandfonline.com/doi/full/10.1080/14760584.2024.2367451
.
79.
U.S. Government Accountability Office.
Electronic Health Records: First Year of CMS’s Incentive Programs Shows Opportunities to Improve Processes to Verify Providers Met Requirements.
https://www.gao.gov/products/gao-12-481 (2012).
84.
Calculated from Orphanet Journal of Rare Diseases (2024). Diseases getting first effective treatment each year.
Calculated from Orphanet Journal of Rare Diseases (2024) https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03398-1 (2024)
Under the current system, approximately 10-15 diseases per year receive their FIRST effective treatment. Calculation: 5% of 7,000 rare diseases ( 350) have FDA-approved treatment, accumulated over 40 years of the Orphan Drug Act = 9 rare diseases/year. Adding 5-10 non-rare diseases that get first treatments yields 10-20 total. FDA approves 50 drugs/year, but many are for diseases that already have treatments (me-too drugs, second-line therapies). Only 15 represent truly FIRST treatments for previously untreatable conditions.
85.
NIH. NIH budget (FY 2025).
NIH https://www.nih.gov/about-nih/organization/budget (2024)
The budget total of $47.7 billion also includes $1.412 billion derived from PHS Evaluation financing... Additional sources: https://www.nih.gov/about-nih/organization/budget | https://officeofbudget.od.nih.gov/
.
86.
Bentley et al. NIH spending on clinical trials: 3.3%.
Bentley et al. https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/ (2023)
NIH spent $8.1 billion on clinical trials for approved drugs (2010-2019), representing 3.3% of relevant NIH spending. Additional sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/ | https://catalyst.harvard.edu/news/article/nih-spent-8-1b-for-phased-clinical-trials-of-drugs-approved-2010-19-10-of-reported-industry-spending/
.
87.
PMC. Standard medical research ROI ($20k-$100k/QALY).
PMC: Cost-effectiveness Thresholds Used by Study Authors https://pmc.ncbi.nlm.nih.gov/articles/PMC10114019/ (1990)
Typical cost-effectiveness thresholds for medical interventions in rich countries range from $50,000 to $150,000 per QALY. The Institute for Clinical and Economic Review (ICER) uses a $100,000-$150,000/QALY threshold for value-based pricing. Between 1990-2021, authors increasingly cited $100,000 (47% by 2020-21) or $150,000 (24% by 2020-21) per QALY as benchmarks for cost-effectiveness. Additional sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10114019/ | https://icer.org/our-approach/methods-process/cost-effectiveness-the-qaly-and-the-evlyg/
.
88.
Xia et al., Nature Food. Nuclear winter famine.
Xia et al. https://www.nature.com/articles/s43016-022-00573-0 (2022)
We estimate that a nuclear war between the United States and Russia would produce 150 Tg of soot and lead to 5 billion people dying at the end of year 2. Additional sources: https://www.nature.com/articles/s43016-022-00573-0
.
89.
Manhattan Institute. RECOVERY trial 82× cost reduction.
Manhattan Institute: Slow Costly Trials https://manhattan.institute/article/slow-costly-clinical-trials-drag-down-biomedical-breakthroughs RECOVERY trial: $500 per patient ($20M for 48,000 patients = $417/patient) Typical clinical trial: $41,000 median per-patient cost Cost reduction: 80-82× cheaper ($41,000 ÷ $500 ≈ 82×) Efficiency: $50 per patient per answer (10 therapeutics tested, 4 effective) Dexamethasone estimated to save >630,000 lives Additional sources: https://manhattan.institute/article/slow-costly-clinical-trials-drag-down-biomedical-breakthroughs | https://pmc.ncbi.nlm.nih.gov/articles/PMC9293394/
.
90.
Trials. Patient willingness to participate in clinical trials.
Trials: Patients’ Willingness Survey https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-1105-3 Recent surveys: 49-51% willingness (2020-2022) - dramatic drop from 85% (2019) during COVID-19 pandemic Cancer patients when approached: 88% consented to trials (Royal Marsden Hospital) Study type variation: 44.8% willing for drug trial, 76.2% for diagnostic study Top motivation: "Learning more about my health/medical condition" (67.4%) Top barrier: "Worry about experiencing side effects" (52.6%) Additional sources: https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-1105-3 | https://www.appliedclinicaltrialsonline.com/view/industry-forced-to-rethink-patient-participation-in-trials | https://pmc.ncbi.nlm.nih.gov/articles/PMC7183682/
.
91.
The Commune. Pentagon audit failures ($2.46T unaccounted).
The Commune https://thecommunemag.com/the-pentagon-misplaced-2-46-trillion-an-in-depth-look-at-the-financial-audit-failures (2024)
In the most recent audit, the Department of Defense (DoD) could not account for approximately 60% of its \(4.1 trillion in assets, amounting to\)2.46 trillion unaccounted for. Alternative title: Pentagon unsupported accounting adjustments (\(6.5T, single year, US Army) In 2015, the Department of Defense's Inspector General reported that the Army could not adequately support\)6.5 trillion in year-end adjustments, indicating severe accounting discrepancies. Additional sources: https://thecommunemag.com/the-pentagon-misplaced-2-46-trillion-an-in-depth-look-at-the-financial-audit-failures | https://accmag.com/audit-pentagon-cannot-account-for-6-5-trillion-dollars-is-taxpayer-money/
.
92.
Tufts CSDD. Cost of drug development.
Various estimates suggest $1.0 - $2.5 billion to bring a new drug from discovery through FDA approval, spread across 10 years. Tufts Center for the Study of Drug Development often cited for $1.0 - $2.6 billion/drug. Industry reports (IQVIA, Deloitte) also highlight $2+ billion figures.
93.
Value in Health. Average lifetime revenue per successful drug.
Value in Health: Sales Revenues for New Therapeutic Agents https://www.sciencedirect.com/science/article/pii/S1098301524027542 Study of 361 FDA-approved drugs from 1995-2014 (median follow-up 13.2 years): Mean lifetime revenue: $15.2 billion per drug Median lifetime revenue: $6.7 billion per drug Revenue after 5 years: $3.2 billion (mean) Revenue after 10 years: $9.5 billion (mean) Revenue after 15 years: $19.2 billion (mean) Distribution highly skewed: top 25 drugs (7%) accounted for 38% of total revenue ($2.1T of $5.5T) Additional sources: https://www.sciencedirect.com/science/article/pii/S1098301524027542
.
94.
Lichtenberg, F. R.
How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000-2013.
International Health 11, 403–416 (2019)
Using 3-way fixed-effects methodology (disease-country-year) across 66 diseases in 22 countries, this study estimates that drugs launched after 1981 saved 148.7 million life-years in 2013 alone. The regression coefficients for drug launches 0-11 years prior (beta=-0.031, SE=0.008) and 12+ years prior (beta=-0.057, SE=0.013) on years of life lost are highly significant (p<0.0001). Confidence interval for life-years saved: 79.4M-239.8M (95 percent CI) based on propagated standard errors from Table 2.
95.
Deloitte. Pharmaceutical r&d return on investment (ROI).
Deloitte: Measuring Pharmaceutical Innovation 2025 https://www.deloitte.com/ch/en/Industries/life-sciences-health-care/research/measuring-return-from-pharmaceutical-innovation.html (2025)
Deloitte’s annual study of top 20 pharma companies by R&D spend (2010-2024): 2024 ROI: 5.9% (second year of growth after decade of decline) 2023 ROI: 4.3% (estimated from trend) 2022 ROI: 1.2% (historic low since study began, 13-year low) 2021 ROI: 6.8% (record high, inflated by COVID-19 vaccines/treatments) Long-term trend: Declining for over a decade before 2023 recovery Average R&D cost per asset: $2.3B (2022), $2.23B (2024) These returns (1.2-5.9% range) fall far below typical corporate ROI targets (15-20%) Additional sources: https://www.deloitte.com/ch/en/Industries/life-sciences-health-care/research/measuring-return-from-pharmaceutical-innovation.html | https://www.prnewswire.com/news-releases/deloittes-13th-annual-pharmaceutical-innovation-report-pharma-rd-return-on-investment-falls-in-post-pandemic-market-301738807.html | https://hitconsultant.net/2023/02/16/pharma-rd-roi-falls-to-lowest-level-in-13-years/
.
96.
Nature Reviews Drug Discovery. Drug trial success rate from phase i to approval.
Nature Reviews Drug Discovery: Clinical Success Rates https://www.nature.com/articles/nrd.2016.136 (2016)
Overall Phase I to approval: 10-12.8% (conventional wisdom 10%, studies show 12.8%) Recent decline: Average LOA now 6.7% for Phase I (2014-2023 data) Leading pharma companies: 14.3% average LOA (range 8-23%) Varies by therapeutic area: Oncology 3.4%, CNS/cardiovascular lowest at Phase III Phase-specific success: Phase I 47-54%, Phase II 28-34%, Phase III 55-70% Note: 12% figure accurate for historical average. Recent data shows decline to 6.7%, with Phase II as primary attrition point (28% success) Additional sources: https://www.nature.com/articles/nrd.2016.136 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6409418/ | https://academic.oup.com/biostatistics/article/20/2/273/4817524
.
97.
SofproMed. Phase 3 cost per trial range.
SofproMed https://www.sofpromed.com/how-much-does-a-clinical-trial-cost Phase 3 clinical trials cost between $20 million and $282 million per trial, with significant variation by therapeutic area and trial complexity. Additional sources: https://www.sofpromed.com/how-much-does-a-clinical-trial-cost | https://www.cbo.gov/publication/57126
.
98.
Ramsberg, J. & Platt, R. Pragmatic trial cost per patient (median $97).
Learning Health Systems https://pmc.ncbi.nlm.nih.gov/articles/PMC6508852/ (2018)
Meta-analysis of 108 embedded pragmatic clinical trials (2006-2016). The median cost per patient was $97 (IQR $19–$478), based on 2015 dollars. 25% of trials cost <$19/patient; 10 trials exceeded $1,000/patient. U.S. studies median $187 vs non-U.S. median $27. Additional sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC6508852/
.
99.
WHO. Polio vaccination ROI.
WHO https://www.who.int/news-room/feature-stories/detail/sustaining-polio-investments-offers-a-high-return (2019)
For every dollar spent, the return on investment is nearly US$ 39." Total investment cost of US$ 7.5 billion generates projected economic and social benefits of US$ 289.2 billion from sustaining polio assets and integrating them into expanded immunization, surveillance and emergency response programmes across 8 priority countries (Afghanistan, Iraq, Libya, Pakistan, Somalia, Sudan, Syria, Yemen). Additional sources: https://www.who.int/news-room/feature-stories/detail/sustaining-polio-investments-offers-a-high-return
.
100.
ICRC. International campaign to ban landmines (ICBL) - ottawa treaty (1997).
ICRC https://www.icrc.org/en/doc/resources/documents/article/other/57jpjn.htm (1997)
ICBL: Founded 1992 by 6 NGOs (Handicap International, Human Rights Watch, Medico International, Mines Advisory Group, Physicians for Human Rights, Vietnam Veterans of America Foundation) Started with ONE staff member: Jody Williams as founding coordinator Grew to 1,000+ organizations in 60 countries by 1997 Ottawa Process: 14 months (October 1996 - December 1997) Convention signed by 122 states on December 3, 1997; entered into force March 1, 1999 Achievement: Nobel Peace Prize 1997 (shared by ICBL and Jody Williams) Government funding context: Canada established $100M CAD Canadian Landmine Fund over 10 years (1997); International donors provided $169M in 1997 for mine action (up from $100M in 1996) Additional sources: https://www.icrc.org/en/doc/resources/documents/article/other/57jpjn.htm | https://en.wikipedia.org/wiki/International_Campaign_to_Ban_Landmines | https://www.nobelprize.org/prizes/peace/1997/summary/ | https://un.org/press/en/1999/19990520.MINES.BRF.html | https://www.the-monitor.org/en-gb/reports/2003/landmine-monitor-2003/mine-action-funding.aspx
.
101.
OpenSecrets.
Revolving door: Former members of congress. (2024)
388 former members of Congress are registered as lobbyists. Nearly 5,400 former congressional staffers have left Capitol Hill to become federal lobbyists in the past 10 years. Additional sources: https://www.opensecrets.org/revolving-door
.
102.
Kinch, M. S. & Griesenauer, R. H.
Lost medicines: A longer view of the pharmaceutical industry with the potential to reinvigorate discovery.
Drug Discovery Today 24, 875–880 (2019)
Research identified 1,600+ medicines available in 1962. The 1950s represented industry high-water mark with >30 new products in five of ten years; this rate would not be replicated until late 1990s. More than half (880) of these medicines were lost following implementation of Kefauver-Harris Amendment. The peak of 1962 would not be seen again until early 21st century. By 2016 number of organizations actively involved in R&D at level not seen since 1914.
103.
Baily, M. N. Pre-1962 drug development costs (baily 1972).
Baily (1972) https://samizdathealth.org/wp-content/uploads/2020/12/hlthaff.1.2.6.pdf (1972)
Pre-1962: Average cost per new chemical entity (NCE) was $6.5 million (1980 dollars) Inflation-adjusted to 2024 dollars: $6.5M (1980) ≈ $22.5M (2024), using CPI multiplier of 3.46× Real cost increase (inflation-adjusted): $22.5M (pre-1962) → $2,600M (2024) = 116× increase Note: This represents the most comprehensive academic estimate of pre-1962 drug development costs based on empirical industry data Additional sources: https://samizdathealth.org/wp-content/uploads/2020/12/hlthaff.1.2.6.pdf
.
104.
Think by Numbers. Pre-1962 physician-led clinical trials.
Think by Numbers: How Many Lives Does FDA Save? https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/ (1966)
Pre-1962: Physicians could report real-world evidence directly 1962 Drug Amendments replaced "premarket notification" with "premarket approval", requiring extensive efficacy testing Impact: New regulatory clampdown reduced new treatment production by 70%; lifespan growth declined from 4 years/decade to 2 years/decade Drug Efficacy Study Implementation (DESI): NAS/NRC evaluated 3,400+ drugs approved 1938-1962 for safety only; reviewed >3,000 products, >16,000 therapeutic claims FDA has had authority to accept real-world evidence since 1962, clarified by 21st Century Cures Act (2016) Note: Specific "144,000 physicians" figure not verified in sources Additional sources: https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/ | https://www.fda.gov/drugs/enforcement-activities-fda/drug-efficacy-study-implementation-desi | http://www.nasonline.org/about-nas/history/archives/collections/des-1966-1969-1.html
.
105.
GAO. 95% of diseases have 0 FDA-approved treatments.
GAO https://www.gao.gov/products/gao-25-106774 (2025)
95% of diseases have no treatment Additional sources: https://www.gao.gov/products/gao-25-106774 | https://globalgenes.org/rare-disease-facts/
.
107.
NHS England; Águas et al. RECOVERY trial global lives saved ( 1 million).
NHS England: 1 Million Lives Saved https://www.england.nhs.uk/2021/03/covid-treatment-developed-in-the-nhs-saves-a-million-lives/ (2021)
Dexamethasone saved 1 million lives worldwide (NHS England estimate, March 2021, 9 months after discovery). UK alone: 22,000 lives saved. Methodology: Águas et al. Nature Communications 2021 estimated 650,000 lives (range: 240,000-1,400,000) for July-December 2020 alone, based on RECOVERY trial mortality reductions (36% for ventilated, 18% for oxygen-only patients) applied to global COVID hospitalizations. June 2020 announcement: Dexamethasone reduced deaths by up to 1/3 (ventilated patients), 1/5 (oxygen patients). Impact immediate: Adopted into standard care globally within hours of announcement. Additional sources: https://www.england.nhs.uk/2021/03/covid-treatment-developed-in-the-nhs-saves-a-million-lives/ | https://www.nature.com/articles/s41467-021-21134-2 | https://pharmaceutical-journal.com/article/news/steroid-has-saved-the-lives-of-one-million-covid-19-patients-worldwide-figures-show | https://www.recoverytrial.net/news/recovery-trial-celebrates-two-year-anniversary-of-life-saving-dexamethasone-result
.
108.
National September 11 Memorial & Museum.
September 11 attack facts. (2024)
2,977 people were killed in the September 11, 2001 attacks: 2,753 at the World Trade Center, 184 at the Pentagon, and 40 passengers and crew on United Flight 93 in Shanksville, Pennsylvania.
109.
World Bank. World bank singapore economic data.
World Bank https://data.worldbank.org/country/singapore (2024)
Singapore GDP per capita (2023): $82,000 - among highest in the world Government spending: 15% of GDP (vs US 38%) Life expectancy: 84.1 years (vs US 77.5 years) Singapore demonstrates that low government spending can coexist with excellent outcomes Additional sources: https://data.worldbank.org/country/singapore
.
110.
International Monetary Fund.
IMF singapore government spending data. (2024)
Singapore government spending is approximately 15% of GDP This is 23 percentage points lower than the United States (38%) Despite lower spending, Singapore achieves excellent outcomes: - Life expectancy: 84.1 years (vs US 77.5) - Low crime, world-class infrastructure, AAA credit rating Additional sources: https://www.imf.org/en/Countries/SGP
.
111.
World Health Organization.
WHO life expectancy data by country. (2024)
Life expectancy at birth varies significantly among developed nations: Switzerland: 84.0 years (2023) Singapore: 84.1 years (2023) Japan: 84.3 years (2023) United States: 77.5 years (2023) - 6.5 years below Switzerland, Singapore Global average: 73 years Note: US spends more per capita on healthcare than any other nation, yet achieves lower life expectancy Additional sources: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-life-expectancy-and-healthy-life-expectancy
.
113.
PMC. Contribution of smoking reduction to life expectancy gains.
PMC: Benefits Smoking Cessation Longevity https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447499/ (2012)
Population-level: Up to 14% (9% men, 14% women) of total life expectancy gain since 1960 due to tobacco control efforts Individual cessation benefits: Quitting at age 35 adds 6.9-8.5 years (men), 6.1-7.7 years (women) vs continuing smokers By cessation age: Age 25-34 = 10 years gained; age 35-44 = 9 years; age 45-54 = 6 years; age 65 = 2.0 years (men), 3.7 years (women) Cessation before age 40: Reduces death risk by 90% Long-term cessation: 10+ years yields survival comparable to never smokers, averts 10 years of life lost Recent cessation: <3 years averts 5 years of life lost Additional sources: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447499/ | https://www.cdc.gov/pcd/issues/2012/11_0295.htm | https://www.ajpmonline.org/article/S0749-3797(24)00217-4/fulltext | https://www.nejm.org/doi/full/10.1056/NEJMsa1211128
.
114.
ICER. Value per QALY (standard economic value).
ICER https://icer.org/wp-content/uploads/2024/02/Reference-Case-4.3.25.pdf (2024)
Standard economic value per QALY: $100,000–$150,000. This is the US and global standard willingness-to-pay threshold for interventions that add costs. Dominant interventions (those that save money while improving health) are favorable regardless of this threshold. Additional sources: https://icer.org/wp-content/uploads/2024/02/Reference-Case-4.3.25.pdf
.
115.
GAO. Annual cost of u.s. Sugar subsidies.
GAO: Sugar Program https://www.gao.gov/products/gao-24-106144 Consumer costs: $2.5-3.5 billion per year (GAO estimate) Net economic cost: $1 billion per year 2022: US consumers paid 2X world price for sugar Program costs $3-4 billion/year but no federal budget impact (costs passed directly to consumers via higher prices) Employment impact: 10,000-20,000 manufacturing jobs lost annually in sugar-reliant industries (confectionery, etc.) Multiple studies confirm: Sweetener Users Association ($2.9-3.5B), AEI ($2.4B consumer cost), Beghin & Elobeid ($2.9-3.5B consumer surplus) Additional sources: https://www.gao.gov/products/gao-24-106144 | https://www.heritage.org/agriculture/report/the-us-sugar-program-bad-consumers-bad-agriculture-and-bad-america | https://www.aei.org/articles/the-u-s-spends-4-billion-a-year-subsidizing-stalinist-style-domestic-sugar-production/
.
116.
World Bank. Swiss military budget as percentage of GDP.
World Bank: Military Expenditure https://data.worldbank.org/indicator/MS.MIL.XPND.GD.ZS?locations=CH 2023: 0.70272% of GDP (World Bank) 2024: CHF 5.95 billion official military spending When including militia system costs: 1% GDP (CHF 8.75B) Comparison: Near bottom in Europe; only Ireland, Malta, Moldova spend less (excluding microstates with no armies) Additional sources: https://data.worldbank.org/indicator/MS.MIL.XPND.GD.ZS?locations=CH | https://www.avenir-suisse.ch/en/blog-defence-spending-switzerland-is-in-better-shape-than-it-seems/ | https://tradingeconomics.com/switzerland/military-expenditure-percent-of-gdp-wb-data.html
.
117.
World Bank. Switzerland vs. US GDP per capita comparison.
World Bank: Switzerland GDP Per Capita https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=CH 2024 GDP per capita (PPP-adjusted): Switzerland $93,819 vs United States $75,492 Switzerland’s GDP per capita 24% higher than US when adjusted for purchasing power parity Nominal 2024: Switzerland $103,670 vs US $85,810 Additional sources: https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=CH | https://tradingeconomics.com/switzerland/gdp-per-capita-ppp | https://www.theglobaleconomy.com/USA/gdp_per_capita_ppp/
.
118.
OECD.
OECD government spending as percentage of GDP. (2024)
OECD government spending data shows significant variation among developed nations: United States: 38.0% of GDP (2023) Switzerland: 35.0% of GDP - 3 percentage points lower than US Singapore: 15.0% of GDP - 23 percentage points lower than US (per IMF data) OECD average: approximately 40% of GDP Additional sources: https://data.oecd.org/gga/general-government-spending.htm
.
119.
OECD.
OECD median household income comparison. (2024)
Median household disposable income varies significantly across OECD nations: United States: $77,500 (2023) Switzerland: $55,000 PPP-adjusted (lower nominal but comparable purchasing power) Singapore: $75,000 PPP-adjusted Additional sources: https://data.oecd.org/hha/household-disposable-income.htm
.
120.
Wikipedia. Thalidomide scandal: Worldwide cases and mortality.
Wikipedia https://en.wikipedia.org/wiki/Thalidomide_scandal The total number of embryos affected by the use of thalidomide during pregnancy is estimated at 10,000, of whom about 40% died around the time of birth. More than 10,000 children in 46 countries were born with deformities such as phocomelia. Additional sources: https://en.wikipedia.org/wiki/Thalidomide_scandal
.
121.
PLOS One. Health and quality of life of thalidomide survivors as they age.
PLOS One https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0210222 (2019)
Study of thalidomide survivors documenting ongoing disability impacts, quality of life, and long-term health outcomes. Survivors (now in their 60s) continue to experience significant disability from limb deformities, organ damage, and other effects. Additional sources: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0210222
.
123.
FDA Study via NCBI. Trial costs, FDA study.
FDA Study via NCBI https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248200/ Overall, the 138 clinical trials had an estimated median (IQR) cost of $19.0 million ($12.2 million-$33.1 million)... The clinical trials cost a median (IQR) of $41,117 ($31,802-$82,362) per patient. Additional sources: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248200/
.
124.
GBD 2019 Diseases and Injuries Collaborators.
Global burden of disease study 2019: Disability weights.
The Lancet 396, 1204–1222 (2020)
Disability weights for 235 health states used in Global Burden of Disease calculations. Weights range from 0 (perfect health) to 1 (death equivalent). Chronic conditions like diabetes (0.05-0.35), COPD (0.04-0.41), depression (0.15-0.66), and cardiovascular disease (0.04-0.57) show substantial variation by severity. Treatment typically reduces disability weights by 50-80 percent for manageable chronic conditions.
125.
WHO. Annual global economic burden of alzheimer’s and other dementias.
WHO: Dementia Fact Sheet https://www.who.int/news-room/fact-sheets/detail/dementia (2019)
Global cost: $1.3 trillion (2019 WHO-commissioned study) 50% from informal caregivers (family/friends, 5 hrs/day) 74% of costs in high-income countries despite 61% of patients in LMICs $818B (2010) → $1T (2018) → $1.3T (2019) - rapid growth Note: Costs increased 35% from 2010-2015 alone. Informal care represents massive hidden economic burden Additional sources: https://www.who.int/news-room/fact-sheets/detail/dementia | https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12901
.
126.
JAMA Oncology. Annual global economic burden of cancer.
JAMA Oncology: Global Cost 2020-2050 https://jamanetwork.com/journals/jamaoncology/fullarticle/2801798 (2020)
2020-2050 projection: $25.2 trillion total ($840B/year average) 2010 annual cost: $1.16 trillion (direct costs only) Recent estimate: $3 trillion/year (all costs included) Top 5 cancers: lung (15.4%), colon/rectum (10.9%), breast (7.7%), liver (6.5%), leukemia (6.3%) Note: China/US account for 45% of global burden; 75% of deaths in LMICs but only 50.0% of economic cost Additional sources: https://jamanetwork.com/journals/jamaoncology/fullarticle/2801798 | https://www.nature.com/articles/d41586-023-00634-9
.
128.
Diabetes Care. Annual global economic burden of diabetes.
Diabetes Care: Global Economic Burden https://diabetesjournals.org/care/article/41/5/963/36522/Global-Economic-Burden-of-Diabetes-in-Adults 2015: $1.3 trillion (1.8% of global GDP) 2030 projections: $2.1T-2.5T depending on scenario IDF health expenditure: $760B (2019) → $845B (2045 projected) 2/3 direct medical costs ($857B), 1/3 indirect costs (lost productivity) Note: Costs growing rapidly; expected to exceed $2T by 2030 Additional sources: https://diabetesjournals.org/care/article/41/5/963/36522/Global-Economic-Burden-of-Diabetes-in-Adults | https://doi.org/10.1016/S2213-8587(17)30097-9
.
130.
World Bank, Bureau of Economic Analysis. US GDP 2024 ($28.78 trillion).
World Bank https://data.worldbank.org/indicator/NY.GDP.MKTP.CD?locations=US (2024)
US GDP reached $28.78 trillion in 2024, representing approximately 26% of global GDP. Additional sources: https://data.worldbank.org/indicator/NY.GDP.MKTP.CD?locations=US | https://www.bea.gov/news/2024/gross-domestic-product-fourth-quarter-and-year-2024-advance-estimate
.
131.
Environmental Working Group. US farm subsidy database and analysis.
Environmental Working Group https://farm.ewg.org/ (2024)
US agricultural subsidies total approximately $30 billion annually, but create much larger economic distortions. Top 10% of farms receive 78% of subsidies, benefits concentrated in commodity crops (corn, soy, wheat, cotton), environmental damage from monoculture incentivized, and overall deadweight loss estimated at $50-120 billion annually. Additional sources: https://farm.ewg.org/ | https://www.ers.usda.gov/topics/farm-economy/farm-sector-income-finances/government-payments-the-safety-net/
.
132.
Drug Policy Alliance.
The drug war by the numbers. (2021)
Since 1971, the war on drugs has cost the United States an estimated $1 trillion in enforcement. The federal drug control budget was $41 billion in 2022. Mass incarceration costs the U.S. at least $182 billion every year, with over $450 billion spent to incarcerate individuals on drug charges in federal prisons.
133.
International Monetary Fund.
IMF fossil fuel subsidies data: 2023 update. (2023)
Globally, fossil fuel subsidies were $7 trillion in 2022 or 7.1 percent of GDP. The United States subsidies totaled $649 billion. Underpricing for local air pollution costs and climate damages are the largest contributor, accounting for about 30 percent each.
134.
Papanicolas, Irene et al. Health care spending in the united states and other high-income countries.
Papanicolas et al. https://jamanetwork.com/journals/jama/article-abstract/2674671 (2018)
The US spent approximately twice as much as other high-income countries on medical care (mean per capita: $9,892 vs $5,289), with similar utilization but much higher prices. Administrative costs accounted for 8% of US spending vs 1-3% in other countries. US spending on pharmaceuticals was $1,443 per capita vs $749 elsewhere. Despite spending more, US health outcomes are not better. Additional sources: https://jamanetwork.com/journals/jama/article-abstract/2674671
.
135.
Hsieh, C.-T. & Moretti, E. Housing constraints and spatial misallocation.
American Economic Journal: Macroeconomics https://www.aeaweb.org/articles?id=10.1257/mac.20170388 (2019)
We quantify the amount of spatial misallocation of labor across US cities and its aggregate costs. Tight land-use restrictions in high-productivity cities like New York, San Francisco, and Boston lowered aggregate US growth by 36% from 1964 to 2009. Local constraints on housing supply have had enormous effects on the national economy. Additional sources: https://www.aeaweb.org/articles?id=10.1257/mac.20170388
.
137.
Tax Foundation. Tax compliance costs the US economy $546 billion annually.
https://taxfoundation.org/data/all/federal/irs-tax-compliance-costs/ (2024)
Americans will spend over 7.9 billion hours complying with IRS tax filing and reporting requirements in 2024. This costs the economy roughly $413 billion in lost productivity. In addition, the IRS estimates that Americans spend roughly $133 billion annually in out-of-pocket costs, bringing the total compliance costs to $546 billion, or nearly 2 percent of GDP.
138.
Cook, C., Cole, G., Asaria, P., Jabbour, R. & Francis, D. P. Annual global economic burden of heart disease.
International Journal of Cardiology https://www.internationaljournalofcardiology.com/article/S0167-5273(13)02238-9/abstract (2014)
Heart failure alone: $108 billion/year (2012 global analysis, 197 countries) US CVD: $555B (2016) → projected $1.8T by 2050 LMICs total CVD loss: $3.7T cumulative (2011-2015, 5-year period) CVD is costliest disease category in most developed nations Note: No single $2.1T global figure found; estimates vary widely by scope and year Additional sources: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001258
.
139.
Source: US Life Expectancy FDA Budget 1543-2019 CSV.
US life expectancy growth 1880-1960: 3.82 years per decade. (2019)
Pre-1962: 3.82 years/decade Post-1962: 1.54 years/decade Reduction: 60% decline in life expectancy growth rate Additional sources: https://ourworldindata.org/life-expectancy | https://www.mortality.org/ | https://www.cdc.gov/nchs/nvss/mortality_tables.htm
.
140.
Source: US Life Expectancy FDA Budget 1543-2019 CSV.
Post-1962 slowdown in life expectancy gains. (2019)
Pre-1962 (1880-1960): 3.82 years/decade Post-1962 (1962-2019): 1.54 years/decade Reduction: 60% decline Temporal correlation: Slowdown occurred immediately after 1962 Kefauver-Harris Amendment Additional sources: https://ourworldindata.org/life-expectancy | https://www.mortality.org/ | https://www.cdc.gov/nchs/nvss/mortality_tables.htm
.
141.
Centers for Disease Control and Prevention.
US life expectancy 2023. (2024)
US life expectancy at birth was 77.5 years in 2023 Male life expectancy: 74.8 years Female life expectancy: 80.2 years This is 6-7 years lower than peer developed nations despite higher healthcare spending Additional sources: https://www.cdc.gov/nchs/fastats/life-expectancy.htm
.
142.
US Census Bureau.
US median household income 2023. (2024)
US median household income was $77,500 in 2023 Real median household income declined 0.8% from 2022 Gini index: 0.467 (income inequality measure) Additional sources: https://www.census.gov/library/publications/2024/demo/p60-282.html
.
143.
Manuel, D. U.s. Defense spending history: 100 years of military budgets.
DaveManuel.com https://www.davemanuel.com/us-defense-spending-history-military-budget-data.php (2025)
US military spending in constant 2024 dollars: 1939 $29B (pre-WW2 baseline), 1940 $37B, 1944 $1,383B, 1945 $1,420B (peak), 1946 $674B, 1947 $176B, 1948 $117B, 2024 $886B. The post-WW2 demobilization cut spending 88% in two years (1945-1947). Current peacetime spending ($886B) is 30x the pre-WW2 baseline and 62% of peak WW2 spending, in inflation-adjusted dollars.
144.
Statista. US military budget as percentage of GDP.
Statista https://www.statista.com/statistics/262742/countries-with-the-highest-military-spending/ (2024)
U.S. military spending amounted to 3.5% of GDP in 2024. In 2024, the U.S. spent nearly $1 trillion on its military budget, equal to 3.4% of GDP. Additional sources: https://www.statista.com/statistics/262742/countries-with-the-highest-military-spending/ | https://www.sipri.org/sites/default/files/2025-04/2504_fs_milex_2024.pdf
.
145.
US Census Bureau. Number of registered or eligible voters in the u.s.
US Census Bureau https://www.census.gov/newsroom/press-releases/2025/2024-presidential-election-voting-registration-tables.html (2024)
73.6% (or 174 million people) of the citizen voting-age population was registered to vote in 2024 (Census Bureau). More than 211 million citizens were active registered voters (86.6% of citizen voting age population) according to the Election Assistance Commission. Additional sources: https://www.census.gov/newsroom/press-releases/2025/2024-presidential-election-voting-registration-tables.html | https://www.eac.gov/news/2025/06/30/us-election-assistance-commission-releases-2024-election-administration-and-voting
.
146.
U.S. Senate. Treaties.
U.S. Senate https://www.senate.gov/about/powers-procedures/treaties.htm The Constitution provides that the president ’shall have Power, by and with the Advice and Consent of the Senate, to make Treaties, provided two-thirds of the Senators present concur’ (Article II, section 2). Treaties are formal agreements with foreign nations that require two-thirds Senate approval. 67 senators (two-thirds of 100) must vote to ratify a treaty for it to take effect. Additional sources: https://www.senate.gov/about/powers-procedures/treaties.htm
.
147.
Federal Election Commission.
Statistical summary of 24-month campaign activity of the 2023-2024 election cycle. (2023)
Presidential candidates raised $2 billion; House and Senate candidates raised $3.8 billion and spent $3.7 billion; PACs raised $15.7 billion and spent $15.5 billion. Total federal campaign spending approximately $20 billion. Additional sources: https://www.fec.gov/updates/statistical-summary-of-24-month-campaign-activity-of-the-2023-2024-election-cycle/
.
148.
OpenSecrets.
Federal lobbying hit record $4.4 billion in 2024. (2024)
Total federal lobbying reached record $4.4 billion in 2024. The $150 million increase in lobbying continues an upward trend that began in 2016. Additional sources: https://www.opensecrets.org/news/2025/02/federal-lobbying-set-new-record-in-2024/
.
149.
Columbia/NBER. Odds of a single vote being decisive in a u.s. Presidential election.
Columbia/NBER: What Is the Probability Your Vote Will Make a Difference? https://sites.stat.columbia.edu/gelman/research/published/probdecisive2.pdf (2012)
National average: 1 in 60 million chance (2008 election analysis by Gelman, Silver, Edlin) Swing states (NM, VA, NH, CO): 1 in 10 million chance Non-competitive states: 34 states >1 in 100 million odds; 20 states >1 in 1 billion Washington DC: 1 in 490 billion odds Methodology: Probability state is necessary for electoral college win × probability state vote is tied Additional sources: https://sites.stat.columbia.edu/gelman/research/published/probdecisive2.pdf | https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1465-7295.2010.00272.x
.
150.
Hutchinson and Kirk.
Valley of death in drug development. (2011)
The overall failure rate of drugs that passed into Phase 1 trials to final approval is 90%. This lack of translation from promising preclinical findings to success in human trials is known as the "valley of death." Estimated 30-50% of promising compounds never proceed to Phase 2/3 trials primarily due to funding barriers rather than scientific failure. The late-stage attrition rate for oncology drugs is as high as 70% in Phase II and 59% in Phase III trials.
151.
DOT. DOT value of statistical life ($13.6M).
DOT: VSL Guidance 2024 https://www.transportation.gov/office-policy/transportation-policy/revised-departmental-guidance-on-valuation-of-a-statistical-life-in-economic-analysis (2024)
Current VSL (2024): $13.7 million (updated from $13.6M) Used in cost-benefit analyses for transportation regulations and infrastructure Methodology updated in 2013 guidance, adjusted annually for inflation and real income VSL represents aggregate willingness to pay for safety improvements that reduce fatalities by one Note: DOT has published VSL guidance periodically since 1993. Current $13.7M reflects 2024 inflation/income adjustments Additional sources: https://www.transportation.gov/office-policy/transportation-policy/revised-departmental-guidance-on-valuation-of-a-statistical-life-in-economic-analysis | https://www.transportation.gov/regulations/economic-values-used-in-analysis
.
152.
PLOS ONE. Cost per DALY for vitamin a supplementation.
PLOS ONE: Cost-effectiveness of "Golden Mustard" for Treating Vitamin A Deficiency in India (2010) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012046 (2010)
India: $23-$50 per DALY averted (least costly intervention, $1,000-$6,100 per death averted) Sub-Saharan Africa (2022): $220-$860 per DALY (Burkina Faso: $220, Kenya: $550, Nigeria: $860) WHO estimates for Africa: $40 per DALY for fortification, $255 for supplementation Uganda fortification: $18-$82 per DALY (oil: $18, sugar: $82) Note: Wide variation reflects differences in baseline VAD prevalence, coverage levels, and whether intervention is supplementation or fortification Additional sources: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012046 | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0266495
.
155.
PMC. Cost-effectiveness threshold ($50,000/QALY).
PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC5193154/ The $50,000/QALY threshold is widely used in US health economics literature, originating from dialysis cost benchmarks in the 1980s. In US cost-utility analyses, 77.5% of authors use either $50,000 or $100,000 per QALY as reference points. Most successful health programs cost $3,000-10,000 per QALY. WHO-CHOICE uses GDP per capita multiples (1× GDP/capita = "very cost-effective", 3× GDP/capita = "cost-effective"), which for the US ( $70,000 GDP/capita) translates to $70,000-$210,000/QALY thresholds. Additional sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC5193154/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC9278384/
.
156.
Integrated Benefits Institute. Chronic illness workforce productivity loss.
Integrated Benefits Institute 2024 https://www.ibiweb.org/resources/chronic-conditions-in-the-us-workforce-prevalence-trends-and-productivity-impacts (2024)
78.4% of U.S. employees have at least one chronic condition (7% increase since 2021) 58% of employees report physical chronic health conditions 28% of all employees experience productivity loss due to chronic conditions Average productivity loss: $4,798 per employee per year Employees with 3+ chronic conditions miss 7.8 days annually vs 2.2 days for those without Note: 28% productivity loss translates to roughly 11 hours per week (28% of 40-hour workweek) Additional sources: https://www.ibiweb.org/resources/chronic-conditions-in-the-us-workforce-prevalence-trends-and-productivity-impacts | https://www.onemedical.com/mediacenter/study-finds-more-than-half-of-employees-are-living-with-chronic-conditions-including-1-in-3-gen-z-and-millennial-employees/ | https://debeaumont.org/news/2025/poll-the-toll-of-chronic-health-conditions-on-employees-and-workplaces/
.
158.
Sinn, M. P.
Wishocracy: Solving the Democratic Principal-Agent Problem Through Pairwise Preference Aggregation.
https://manual.warondisease.org/knowledge/appendix/wishocracy-paper.html (2025) doi:
10.5281/zenodo.18205881 Representative democracy suffers from an inescapable principal-agent problem where elected officials’ incentives diverge from citizen welfare. Wishocracy introduces RAPPA (Randomized Aggregated Pairwise Preference Allocation), which aggregates citizen preferences through cognitively tractable pairwise comparisons and creates accountability via Citizen Alignment Scores that channel electoral resources toward politicians who actually represent what citizens want.
159.
Sinn, M. P.
The 1% Treaty: Harnessing Greed to Eradicate Disease.
https://manual.warondisease.org/knowledge/economics/1-pct-treaty-impact.html (2025) doi:
10.5281/zenodo.18161560 6.65 thousand diseases have zero FDA-approved treatments; at current trial capacity, exploring them takes 443 years. Redirecting 1% of military spending scales capacity 12.3x, cutting the timeline to 36 years and preventing 10.7 billion deaths. At $0.00177/DALY, 50.3kx more cost-effective than the best existing interventions. Incentive Alignment Bonds make adoption politically viable.
160.
Sinn, M. P.
Optimocracy: Causal Inference on Cross-Jurisdictional Policy Data to Maximize Median Health and Wealth.
https://manual.warondisease.org/knowledge/appendix/optimocracy-paper.html (2025) doi:
10.5281/zenodo.18356213 Thousands of jurisdictions have made different policy and budget choices over decades, creating a natural experiment. Optimocracy applies causal inference to this cross-jurisdictional time-series data to identify which policies predict above-average median income and healthy life years. It then publishes evidence-based recommendations for every major vote, tracks politician alignment, and funds aligned candidates via SuperPAC, making suboptimal policy politically expensive while preserving democratic structures.
161.
Sinn, M. P.
Incentive Alignment Bonds: Making Public Goods Financially and Politically Profitable.
https://manual.warondisease.org/knowledge/appendix/incentive-alignment-bonds-paper.html (2025) doi:
10.5281/zenodo.18203221 Government spending is optimized for lobbying intensity, not net societal value. Programs with 100:1 benefit-cost ratios get billions while programs with negative returns get hundreds of billions. Incentive Alignment Bonds flip this by creating a capital pool that rewards politicians (via campaign support and post-office opportunities) for funding high-NSV programs over low-NSV alternatives. The result: public good becomes private profit for both investors and elected officials.
164.
Sinn, M. P.
The Optimal Budget Generator: A Causal Inference Protocol for Maximizing Median Health and Wealth Through Public Goods Funding.
https://manual.warondisease.org/knowledge/appendix/optimal-budget-generator-spec.html (2025) doi:
10.5281/zenodo.18356209 The Optimal Budget Generator (OBG) uses causal inference, diminishing returns modeling, and cost-effectiveness evidence to determine optimal public goods funding levels that maximize two welfare metrics: real after-tax median income growth and median healthy life years. For each spending category, OBG estimates an Optimal Spending Level (OSL) and produces a gap analysis showing where current government budgets are over- or underfunded relative to evidence-based benchmarks. The Budget Impact Score (BIS) measures confidence in each recommendation based on the quality of causal evidence.